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Abstract 
Nowadays, hearing impaired people can be treated with a multitude of different devices 
and surgical interventions that are selected in function of the type and degree of hearing 
loss of the patient. These known therapies cover the major part of possible hearing losses 
except severe to profound mixed hearing loss. The present thesis results from an 
industrial project that aims to develop a dedicated hearing therapy that treats this kind of 
hearing loss based on direct acoustic cochlear stimulation (DACS). A semi-implantable 
investigational hearing device is used in a clinical trial with four patients to validate this 
novel therapy approach. 
 
The development of this investigational hearing implant presents a considerable 
challenge due to the numerous medical and engineering aspects that have to be 
considered. The conceptual design process is therefore of central importance because it 
incorporates all the relevant aspects and defines the future device characteristics and 
performances. Fundamental design aspects that are not considered at this early design 
stage can only be implemented with difficulties and increased efforts later on. This is the 
motivation to develop within the scope of this thesis a conceptual design methodology 
that supports and facilitates this essential design phase. 
 
A conceptual design methodology for acoustic hearing implants is therefore presented at 
the example of the DACS investigational device. The methodology consists of a four-step-
procedure and a system diagram tool. 
 
The four steps of the procedure are: 
? Step 1: determination and analysis of the human body functions that shall be 
emulated by the system 
? Step 2: determination of the preliminary system architecture 
? Step 3: determination of the user and system requirements 
? Step 4: conceptual design 
 
The system diagram tool guides the engineer through all four steps and helps visualizing 
and structuring the system environments, functions, interfaces and, most important, all 
interactions between the system elements and environments. The diagram drawing rules 
ensure that all requirements coming from the environments are correctly linked with the 
concerned system functions and therefore ensure that the system meets all these 
requirements. Finally, the system diagram is a valuable tool for the conceptual design 
step. Because of the clearly represented system elements and interactions, it supports 
the development of integrated solutions. 
 
The output of the presented methodology is a design concept that cannot be directly 
quantified to assess the benefit of the methodology. Only once the resulting device is 
   
successfully verified against the system requirements and validated against the user 
requirements, it can be concluded that the underlying concept is adequate.  
 
The outcome of the clinical study shows that the four implanted patients benefit all from 
the DACS device, which is therefore well suited to treat severe to profound mixed hearing 
loss. This confirms that device meets the user requirements and implies that conceptual 
design methodology is adequate.  
 
The realized investigational device consists of an externally worn audio processor, a 
percutaneous connector, and an implantable actuator. The hermetically sealed balanced 
armature actuator provides a maximal equivalent sound pressure level of 125 dB over the 
frequency range between 100 Hz and 10’000 Hz with a limited 1-mW power supply. A 
lumped parameter model of the actuator dynamics and a finite element model of the 
electro-mechanic actuator are used for the detailed actuator design. 
 
Key Words 
Conceptual design methodology, system diagram, integrated solution, implantable 
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transducer 
 
   
  
Résumé 
Aujourd’hui, des personnes malentendantes peuvent profiter de nombreux types 
d’appareils et d’interventions chirurgicales, qui sont choisis en fonction du type et du 
degré de la surdité du patient. Ces thérapies connues couvrent la majorité des surdités 
possibles à l’exception de la surdité mixte de sévère à grave. Cette thèse résulte d’un 
projet industriel, qui a comme but le développement d’une thérapie appropriée pour traiter 
ce type de surdité, basée sur la stimulation acoustique directe de la cochlée (DACS). Un 
appareil acoustique semi-implantable est utilisé pour valider cette nouvelle approche 
dans une étude clinique avec quatre patients. 
 
Le développement de l’appareil acoustique d’essai est un défi considérable parce que de 
nombreux aspects médicaux et techniques doivent être considérés. Voilà pourquoi le 
processus de design conceptuel est d’une importance centrale parce qu’il incorpore tous 
les aspects fondamentaux et définif les futures caractéristiques et performances de 
l’appareil. Des aspects de design fondamentaux, qui ne sont pas considérés dès le début 
de l’étude, ne peuvent qu’être difficilement implémentés et causent des efforts plus 
importants par la suite. C’est la motivation pour développer dans le cadre de cette thèse 
une méthode de design conceptuel qui assiste et facilite cette phase de design 
essentielle. 
 
Une méthode de design conceptuel pour des implants auditifs acoustiques est donc 
présentée avec l’exemple de l’appareil d’essai DACS. La méthode est constituée d’une 
procédure en quatre étapes et d’un outil pour la représentation graphique du système. 
 
Les quatre étapes de la procédure sont : 
? Pas 1 : détermination et analyse des fonctions corporelles humaines qui doivent 
être émulées par le système 
? Pas 2 : détermination de l’architecture préliminaire du système 
? Pas 3 : détermination des exigences de l’utilisateur et du système 
? Pas 4 : design conceptuel 
 
L’outil pour la représentation graphique du système guide l’ingénieur à travers les quatre 
étapes et aide à visualiser et structurer les environnements du système, ses fonctions, 
ses interfaces et, le plus important, toutes les interactions entre les éléments du système 
et les environnements. Les règles de la représentation graphique assurent que toutes les 
exigences imposées par les environnements sont correctement attribuées aux éléments 
concernés du système. Cela assure que le système remplit toutes les exigences. 
Finalement, la représentation graphique du système est aussi un outil valable pour le 
design conceptuel. Grâce à la représentation explicite des éléments du système et les 
   
interactions correspondantes, elle assiste et permet le développement de solutions 
intégrales. 
 
Le résultat de la méthode présentée est un concept de design qui ne peut pas être 
directement quantifié pour vérifier le bénéfice de la méthode. Ce n’est qu’après 
vérification par rapport aux exigences du système et après validation par rapport aux 
exigences de l’utilisateur de l’appareil résultant, qu’il est possible de conclure que le 
design conceptuel est adéquat. 
 
Les résultats de l’étude clinique montrent que les quatre patients profitent de l’appareil 
DACS, qui est bien adapté pour traiter la surdité mixte de sévère à grave. Cela confirme 
que l’appareil remplit les exigences de l’utilisateur et implique que la méthode de design 
conceptuel est adéquate. 
 
L’appareil d’essai réalisé est constitué d’un processeur audio externe, d’un connecteur 
percutané et d’un actionneur implantable. L’actionneur à armature balancée, qui est 
hermétiquement encapsulé, génère une pression sonore équivalente de 125 dB dans une 
gamme de fréquence de 100 Hz à 10'000 Hz avec une alimentation limitée à 1 mW. Un 
schéma équivalent mécanique-électrique est utilisé pour simuler les caractéristiques 
dynamiques de l’actionneur. La conversion électromagnétique est simulée avec un 
modèle à éléments finis. 
 
Mots clés 
Méthode de design conceptuel, diagramme de système, solution intégrée, implant auditif, 
surdité mixte, actionneur à armature balancée, transducteur avec encapsulation 
hermétique 
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1 Introduction 
1.1 Motivation 
Cochlear Acoustics Ltd., Lausanne, Switzerland – a joint venture of Cochlear Ltd., 
Sidney, Australia and Phonak AG, Stäfa, Switzerland – decided to develop and market a 
novel hearing implant for the treatment of severe to profound mixed hearing loss based 
on direct acoustical cochlear stimulation (DACS). In a first step, an investigational device 
should be designed, fabricated, homologated and validated in a clinical study. 
 
Cochlear Acoustics Ltd. mandated Helbling Technik Bern AG, Liebefeld, Switzerland for 
the development of this investigational DACS device. Thereupon the device development 
was tackled in close collaboration with the Inselspital, Bern, Switzerland and the Cochlear 
Technology Center, Mechelen, Belgium. 
 
Several implantable hearing devices were already commercially available at the 
beginning of the project, but no one seemed to have a broad market acceptance. 
Therefore it seemed reasonable to investigate the reasons for this low acceptance in 
order to prevent doing the same mistakes. 
 
One of the reasons seems to be the non-satisfactory therapeutic performance of the 
existing devices. All of them have disadvantages that are not accepted by the users; such 
as low output, deterioration of residual hearing or insufficient device reliability. These 
disadvantages are of conceptual nature in most of the cases and can not be eliminated by 
just a design refinement. This is the starting point for the present thesis. As part of the 
DACS investigational device project it should be investigated how to optimize the 
conceptual design process in order to provide more satisfying solutions. 
 
This theoretical work should include the analysis of the conceptual design process in this 
particular case of acoustic hearing implants, the development of a dedicated conceptual 
design methodology and its application in the case of the DACS investigational device. 
The methodology should support the engineer during the conceptual design process and 
minimize the risk of wrong conceptual design decisions.  
 
1.2 Anatomy and Physiology of the Ear 
This is a brief introduction of the anatomy and the physiology of the ear given to provide 
sufficient basics to follow this work. For more detailed information the reader is referred to 
corresponding specialist literature. 
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1.2.1 Overview 
Fig. 1-1 shows a section through the human ear with its three main parts. The outer ear 
comprises the pinna and the auditory canal. The tympanic membrane separates the outer 
ear from the middle ear, which consists of the tympanic cavity including the three middle 
ear ossicles. The cochlea, the equilibrium organ and the auditory nerve build the inner 
ear. 
 
The hearing capability of the human ear is impressive. A young and healthy person can 
hear sounds in the frequency range from 20 Hz to 20’000 Hz and sound levels from the 
hearing threshold of 0 dB SPL at 2 kHz (sound pressure level, reference is 20 μPa) to the 
pain threshold of 125 dB SPL. 
 
 
Fig. 1-1:  Section through the human ear showing the outer, middle and inner ear [1] 
 
1.2.2 Outer Ear 
The outer ear fulfills two main functions. On the one hand it protects the sensible 
structures of the middle and inner ear by impeding access. On the other hand it affects 
the incoming sound signals to help localizing the sound source and provides amplification 
of the frequencies around 3 kHz due to resonance effects.  
  3 
  
1.2.3 Middle Ear 
The middle ear comprises the tympanic membrane that transforms the sound pressure 
wave into a mechanical vibration of the three ossicles: malleus, incus and stapes. The 
stapes is coupled to the cochlea at the oval window and re-converts the vibrations into a 
pressure wave that is eventually released into the cochlea as shown in Fig. 1-2. 
 
The middle ear provides multiple physiological functions. The most important one is to 
maximize the sound transmission from the outer to the inner ear by adapting the acoustic 
impedance. Since the cochlea is fluid filled, a direct coupling to the incoming air pressure 
wave would cause considerable transmission losses of 99.96%. Therefore the middle ear 
increases the transmitted pressure by reducing the coupling surface from 55 mm2 
(tympanic membrane) to 3.2 mm2 (oval window) and by applying a lever arm formed by 
the malleus and the incus (lever ratio is approximately 1.3). Both effects together cause a 
22-time amplification of the transmitted pressure, which limits the transmission losses. 
 
The second function is to compensate static pressure changes. In order to keep the 
stapes foot plate at its nominal position in cases of air pressure changes (e.g. when 
blowing one’s nose), the joints between the three ossicles allow for an adjustment of their 
relative position. 
 
 
Fig. 1-2:  The middle ear [1] 
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Additionally there are two muscles attached to the ossicular chain that can damp the 
sound transmission when contracting. The explanation of this mechanism is still under 
discussion. Probable functions are the protection against very loud sounds, the 
attenuation of the own voice and the increase of speech intelligibility in noise. 
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Fig. 1-3:  Section through the cochlea showing the three parallel canals 
and the organ of Corti containing the basilar membrane with the hair cells [1] 
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1.2.4 Inner Ear 
Fig. 1-3 shows how the cochlea is build up. It contains three parallel canals (scalae). The 
scala vestibuli starts at the oval window and mounts towards the apex of the cochlea 
where it joins the scala tympani at the helicotrema (the passage between the two canals). 
From the helicotrema the scale tympani descends until it ends at round window which is 
closed towards the middle ear by a thin membrane. The scala media is in between the 
scala vestibule and the scala tympani and represents a self-contained volume. 
 
The most important part of the cochlea that converts the pressure signals into electrical 
nerve impulses (action potentials) is the organ of Corti. It consists of the basilar 
membrane, the tectorial membrane and the hair cells. If a pressure wave is released into 
the scala vestibuli at the oval window, it propagates through the cochlea and excites the 
basilar membrane. This is comparable to picking a chord of a guitar. The basilar 
membrane starts to oscillate which causes a relative translation between the basilar 
membrane and the fixed tectorial membrane. The hair cells, which sit on the basilar 
membrane while the stereocilia (hairs) are in contact with the tectorial membrane, detect 
this relative translation and convert it into action potentials. Due to the special mechanical 
properties of the basilar membrane it oscillates very locally depending on the sound 
frequency. As shown in Fig. 1-4, high frequencies cause oscillation near the base of the 
cochlea and low frequencies near the apex. 
 
 
Fig. 1-4:  Response of the basilar membrane to sound [1] 
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1.3 Hearing Disorders 
1.3.1 Types of Hearing Loss 
There are two main steps from a sound pressure signal to the corresponding perception 
in the auditory center of the brain. 
 
First, the sound pressure signal has to be “conducted” through the outer and the middle 
ear to the inner ear. If this sound transmission is impaired in some way, a conductive 
hearing loss is the consequence. 
 
In a second step, the hair cells transform the movements of the inner ear liquid into action 
potentials that are transmitted through the auditory nerve to the auditory center of the 
brain. An impairment of this part of the sound transmission and perception is called 
sensorineural hearing loss. 
 
Cases that combine conductive and sensorineural hearing losses are called combined or 
mixed hearing loss. 
 
1.3.2 Assessment of Hearing Disorder – The Audiogram 
The main tool to assess the type and degree of hearing loss of a patient is the audiogram 
(Fig. 1-5). It contains the hearing thresholds for multiple frequencies in comparison to a 
normal, healthy ear. The thresholds are normally assessed at 125, 250, 500, 1000, 2000, 
3000, 4000 and 8000 Hz. They are measured in dB HL (hearing loss) where 0 dB HL 
refers to the threshold of a healthy ear (Fig. 2-25). The gray-shaded area indicates the 
frequencies and sound levels that correspond to speech. Due to its characteristic shape it 
is also called “speech banana”. 
 
 
Fig. 1-5:  Audiogram grid 
  7 
  
Two different hearing thresholds can be assessed: air conduction thresholds and bone 
conduction thresholds. 
 
To assess the air conduction thresholds, pure tones are provided to the patient by 
earphones. For each assessed frequency the sound level is continuously increased until 
the patient perceives the signal. The air conduction thresholds are indicated by circles in 
case of a right and crosses in case of a left ear. This measurement assesses the overall 
hearing loss, i.e. the sum of conductive and sensorineural hearing loss. 
 
The bone conduction thresholds are assessed in the same way as the air conduction 
thresholds but instead of providing a sound pressure signal, corresponding vibrations are 
applied on the patient’s temple. A special bone conduction headset containing a 
transducer that generates vibrations is used for this purpose. These vibrations bypass the 
outer and middle ear and are directly transmitted to the inner ear through the cranial 
bones. Therefore this measurement only assesses the sensorineural part of a hearing 
loss. The bone conduction thresholds are indicated by “>” in case of a right and “<” in 
case of a left ear. 
 
The difference between these two thresholds is called air-bone-gap and indicates the 
conductive loss. 
 
Fig. 1-6 shows an example of a patient that suffers from profound mixed hearing loss. 
Since air and bone conduction thresholds are not congruent, they form an air-bone-gap 
indicating the conductive loss of the patient. The sensorineural loss is indicated by the 
bone conduction thresholds. The overall loss is shown by the air conduction thresholds 
 
Air-bone-gap
 
Fig. 1-6:  Audiogram indicating air and bone conduction thresholds of a left ear 
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representing the actual impairment of the patient. One can see that the air conduction 
thresholds are far below the area where a normal conversation takes place (speech 
banana). Hence this patient would not hear a person talking to him at normal sound 
levels. The goal of every hearing therapy is therefore to lift the thresholds in aided 
condition close to the upper edge of the speech banana. 
 
1.4 Hearing Therapies 
1.4.1 Overview 
Fig. 1-7 maps the existing hearing therapies according to the degree and type of hearing 
loss [2] - [4]. It can be observed that pure sensorineural and pure conductive losses are 
well covered by known therapies. This is not the case with severe to profound mixed 
hearing loss. Only a combination of two therapies could partially restore the hearing of 
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Fig. 1-7:  Overview of hearing therapies according to degree and type of hearing loss. 
HA: conventional hearing aids, MES: middle ear surgery, CI: cochlear 
implants, MEI: middle ear implants, BAHA: bone anchored hearing aids and, 
DACS: direct acoustic cochlear stimulation, modified after [2] 
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patients with such impairment. Therefore the goal of the present project was to develop a 
dedicated therapy for severe to profound mixed hearing loss based on an implantable 
hearing device (gray-shaded area). The corresponding direct acoustic cochlea stimulation 
(DACS) approach is described in sub-section 1.5.2. 
 
1.4.2 Hearing Aids 
Hearing aids are the most widely-used hearing therapy. Approximately 6 - 7 million units 
are sold per year [5]. They are used to treat pure sensorineural and mild to moderate 
mixed hearing loss. By principle they are not adapted to treat conductive hearing loss 
since they rely on a functional middle ear for sound transmission. Any sound signal would 
therefore be damped by the conductive impairment. 
 
The operation principle of conventional hearing aids is as follows: They collect sound by 
one or more microphones, amplify it according to the hearing impairment of the patient 
and emit the amplified sound into the auditory canal. Fig. 1-8 shows different 
implementations of conventional hearing aids. Their size increases in general with the 
provided output power. A CIC is indicated for mild to moderate hearing loss, where a BTE 
is able to threat severe hearing loss. 
 
Fig. 1-8:  Conventional hearing aids, from left to the right: completely in the canal 
device (CIC), in the canal device (ITC), micro behind the ear device (micro 
BTE), behind the ear device (BTE) [6] 
 
1.4.3 Middle Ear Surgery 
Middle ear surgery is able to restore conductive hearing loss by the implantation of 
passive prostheses. Missing, injured or immobile structures can be replaced by 
corresponding artificial structures. Fig. 1-9 shows three examples. 
 
A stapes prosthesis is used in case of an immobile stapes (otosclerosis). After removing 
the stapes supra-structure and having drilled a hole into the immobile foot plate, the 
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stapes prosthesis is placed into the hole in the foot plate and attached to the incus. In this 
way the sound transmission is again unobstructed from the outer to the inner ear. This 
surgical technique is called stapedectomy [7], [8]. 
 
A total ossicular chain replacement prosthesis (TORP) is coupled to the inner ear like a 
stapes prosthesis, but replaces all the three ossicles. The wheel shaped part is therefore 
placed directly on the tympanic membrane. 
 
If the joint between the incus and the stapes (incudo-stapedial joint) is injured, it is 
possible to remove the tip of the long incus process and to reestablish the ossicular chain 
with help of the prosthesis shown on the right. 
 
 
Fig. 1-9:  Middle ear prostheses: stapes prosthesis on the left, total ossicular chain 
replacement prosthesis (TORP) in the middle and replacement of incudo-
stapedial joint on the right [9] 
 
1.4.4 Bone anchored hearing aids 
A bone anchored hearing aid (Fig. 1-10) is an alternative treatment for conductive hearing 
loss and can also be used in case of mild mixed hearing loss. It consists of a vibrating 
device that is coupled to the cranial bone by means of an implanted bone screw. The  
 
 
Fig. 1-10:  Bone anchored hearing aid: screw implant on the left, percutaneous 
abutment in the middle and external vibrator on the right [10] 
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vibrating device itself stays outside the head and is attached to the implanted screw via a 
percutaneous abutment. The vibrations are transmitted through the cranial bone directly 
to the inner ear while bypassing the outer and middle ear. For this reason it does not rely 
on a functional outer nor middle ear and is adapted to treat conductive hearing loss. The 
transmitted vibrations are on the other hand not strong enough to compensate for 
moderate to profound sensorineural hearing loss. 
 
1.4.5 Cochlear Implants 
If there are no functional hair cells left that transform an acoustical stimulation into 
corresponding action potentials (sub-section 1.2.4), it is ineffective to amplify the sound 
signal. In this case it is only possible to directly stimulate electrically the auditory nerves 
with a cochlear implant (CI). Fig. 1-11 shows the components of a CI. The external audio 
processor looks like a conventional BTE hearing aid. It provides identical functions but 
does not contain a loudspeaker. Instead the sound signals are encoded and provided to a 
transmitter coil. The implanted receiver coil captures these signals and the implanted 
electronics converts them into a specific stimulation pattern of the multiple electrode 
contacts. As explained in sub-section 1.2.4 the contacts next to the electrode tip stimulate 
the low frequencies and the contacts at the electrode base stimulate the high frequencies. 
 
 
Fig. 1-11:  Cochlear implant (Cochlear Nucleus 5): audio processor on the left, implant 
in the middle and a magnified view of the stimulation electrode on the right 
[11] 
 
1.4.6 Middle Ear Implants 
Middle ear implants function in first instance similar to a conventional hearing aid. Sound 
is captured by microphones and amplified according to the hearing loss of the patient; but 
instead of emitting an amplified sound pressure signal, a small implantable actuator 
generates vibrations that are coupled to one of the middle ear ossicles [12] - [18]. 
 
Fig. 1-12 shows an example of such a device. In this case, the actuator is uniquely 
attached to the incus (sub-section 2.2.2, Soundbridge). Other devices provide actuators 
that are anchored in the temporal bone and have an output structure that is attached to 
one of the ossicles (sub-section 2.2.2, TICA, M.E.T., Carina and Esteem). Since middle 
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ear implants use the ossicular chain as a coupling structure to transmit the vibrations to 
the inner ear, they are not indicated for conductive or mixed hearing loss. 
 
 
Fig. 1-12:  Middle ear implant (Vibrant Soundbridge): actuator on the left, 
external audio processor in the middle and implant electronics on the right 
[19] 
 
1.5 DACS Therapy Concept 
1.5.1 State of the Art 
As presented in sub-section 1.4.1, there is not yet a dedicated therapy for severe to 
profound mixed hearing loss. Patients are normally treated either with a conventional 
hearing aid or the combination of a conventional hearing aid and stapedectomy. This 
combined therapy, which is considered as reference for this project, provides better 
results than a hearing aid only but includes the drawbacks of both therapies. A direct 
comparison between this reference method and the DACS therapy will be the major 
outcome of the clinical study and will be presented in section 5.3. 
 
Recently there were a lot of efforts made to expand the indication of existing middle ear 
implants for mixed hearing loss. Since these devices originally relied on a functional 
middle ear, it was necessary to modify them and to develop new surgical techniques. 
 
The Vibrant Soundbridge was recently approved for the treatment of mixed hearing loss. 
In this case, the device is not attached to the ossicular chain but is rather placed on the 
round window membrane to bypass the middle ear [20]. 
 
A similar approach is under investigation for the Carina device. Here, the actuator is 
coupled to the round window membrane as well by means of specially shaped coupling 
elements [21]. 
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1.5.2 The DACS Approach 
As introduced in sub-section 1.3.1, mixed hearing loss combines sensorineural and 
conductive losses what can cause very high hearing thresholds. Devices that make use of 
the natural sound transmission structures of the ear (i.e. outer and middle ear), such as 
conventional hearing aids and middle ear implants, have therefore to provide 
correspondingly high output power to compensate for the conductive losses and still 
provide a sufficiently amplified signal to the cochlea. 
 
A more efficient approach is to bypass the natural sound transmission structures of the 
ear in order to directly provide an amplified signal to the cochlea. In this way the 
conductive losses have no longer to be compensated by increased output power and the 
required amplification is determined by the sensorineural hearing loss only. This novel 
approach is called direct acoustic cochlear stimulation, abbreviated as DACS. From a 
medical point of view, the coupling to the inner ear is the most critical aspect of this 
approach. Therefore, it was decided to make use of a well-known, standard surgical 
procedure that establishes access to the cochlea for sound transmission: stapedectomy 
(sub-section 1.4.3). In order to keep this procedure as unchanged as possible and to 
allow the surgeon to use his preferred stapes prosthesis, the concept of an artificial incus 
was developed. An actuator with an output structure looking like a long incus process 
provides amplified vibrations as shown in Fig. 1-13.  
 
Stapes footplate(stapes supra structure
was surgically removed)
Cochlea
Actuator
Outer ear
canal
Stapes
prosthesis
Tympanic
membrane
Round window
Incus
body
Malleus
Long
incus
process
Artificial
incus
Short
incus
process
 
Fig. 1-13:  Implantation of the DACS actuator: The stapes supra structure is surgically 
removed; a stapes prosthesis is inserted into a stapes foot plate fenestration 
and crimped to the artificial incus of the actuator 
 
Fig. 1-14 illustrates how the mixed hearing loss is addressed by the DACS device. The 
direct access to the inner ear via the stapes prosthesis eliminates the conductive part of 
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the hearing loss and closes therefore the air-bone-gap. The amplified deflections 
compensate for the sensorineural hearing loss. Both elements together result in aided 
thresholds that are close to the upper edge of the speech banana. This allows to follow 
again a conversation at normal sound levels. The aided thresholds are indicated by 
triangles (squares in case of a right ear). 
 
 
Fig. 1-14:  DACS therapy concept 
 
1.6 About this Work 
1.6.1 The Specific Challenges 
Designing an acoustical hearing implant means to master multiple challenges. One of 
them is directly linked to the characteristics of hearing. As introduced in sub-section 1.3.2, 
the human ear has a dynamic of over 125 dB. In order to manage this enormous dynamic 
range it perceives loudness exponentially. The minimal, perceptible difference between 
two sound levels depends on the sound level itself and varies between 0.2 dB and 5 dB 
[22]. This means that an output power change of a hearing device of 300% (5 dB) is not 
necessarily perceived by the patient. This seems enormous from a technical device 
perspective and shows that detailed design optimization (e.g. of an electro-mechanic 
transducer) does not address the issue. In fact the right choices have to be made on 
system level in order to achieve the required performance. 
 
A further challenge is to meet all requirements that are specific for active implantable 
medical devices. Safety and reliability are essential and have the same priority as the 
amplification performance. This contradiction has to be addressed by finding good 
compromises or even integrative solutions. Therefore it is again of great importance to 
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make the right conceptual choices on system level and to primarily consider all the 
specific requirements during the whole design process. 
 
The conceptual design phase of an acoustic hearing implant is essential because it 
provides the basis for the subsequent design steps and already defines its major device 
characteristics and performance. Specific implantable device requirements and other 
fundamental design aspects that are not considered at this stage can only be 
implemented with difficulties and increased efforts later on. In a worst case scenario, bad 
choices or neglected requirements during the conceptual design phase can cause 
fundamental device drawbacks that cannot be corrected anymore. 
 
1.6.2 Proposed Approach 
Fig. 1-15 shows the “V-model” that will be used to describe the main development steps 
of medical devices [23]. One can notice that there are two levels of performance that have 
to be considered. Beside the pure technical device performance, it is finally the 
therapeutic performance that represents most important performance level. The overall 
goal is only achieved, if the device successfully treats the patient. Just meeting the 
system requirements is not sufficient. 
 
Therefore the first two and a half steps of the development process are essential to reach 
a good therapeutic result. They include the determination of the user requirements, their 
translation into system requirements and the conceptual design. The second two and a 
half steps result from the previous ones and include the detailed design of the system, its 
verification against the system requirements and the validation against the user 
requirements. 
 
Therapeutic
performance
User
requirements Validation
Technical
performance
System
requirements
System
design
Verification
 
Fig. 1-15:  The V-model that describes the medical device development process 
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In many cases the five design steps are executed in succession and by different people. 
For example, the user requirements are determined by doctors. The system requirements 
are written by a project leader and split into different system building blocks which are 
then designed by corresponding design teams. This approach entails the risks of losing 
the relation to the initial user requirements. This can result in a system that meets the 
system requirements but not necessarily the user requirements. 
In order to minimize this risk, it is proposed to merge the first two and a half steps into one 
conceptual design process as shown in Fig. 1-16. A system engineer that follows the 
whole design process has to be involved from the beginning in order to understand the 
impact of the design decisions on the therapeutic system performance. The challenge is 
now to keep the overview and to structure all the information of the parallelized steps. A 
corresponding methodology is the central part of this thesis and is presented in chapter 2. 
 
Proposed
conceptual
design
process 
User
requirements Validation
System
requirements Verification
Conceptual
design
Detailed
design
 
Fig. 1-16:  Merging of the first two and half steps into one conceptual design process 
 
1.6.3 Thesis Outline 
Fig. 1-17 shows how this thesis is structured. The chapters follow the different steps of 
the V-model. The proposed conceptual design methodology is presented in chapter 2. 
Chapter 3 presents the investigational DACS device including a summary of the detailed 
actuator design process. The system verification tests and corresponding results are 
shown in chapter 4. The clinical study and its outcome, the validation of the system 
against the user requirements are summarized in chapter 5. Finally, chapter 6 contains 
the conclusions and an outlook on future projects. 
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Fig. 1-17:  Thesis outline 
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2 Conceptual Design Methodology for Acoustic Hearing 
Implants 
2.1 Introduction 
The major challenges that have to be addressed by the proposed conceptual design 
methodology are presented in sub-sections 1.6.1 and 1.6.2. In short, they consist in: 
? Understanding exactly the hearing mechanisms and the corresponding user 
requirements 
? Understanding the specific requirements of active implantable medical devices 
? Translating the user requirements correctly into system requirements   
? Considering all relevant requirements at each design step 
? Making the right choices on concept level in order to maximize the system and, 
finally, the therapeutic performance 
 
A two-step investigation is done in order to complete the above list. First, references on 
how to design an acoustic hearing implant are presented (sub-section 2.2.1). Second, the 
already existing acoustic hearing implants are analyzed (sub-section 2.2.2). Finally, sub-
section 2.2.3 summarizes the outcome of the investigation and completes the above list. 
 
2.2 State of the Art 
2.2.1 Design Methodology 
There are numerous conceptual design methodologies that can be used for a general 
device development. Shah [24] has listed and categorized the most widely used 
methodologies like the use of design catalogues, morphological analysis, brainstorming or 
6-3-5, to just mention some examples. 
 
All these methodologies are valuable tools to find solutions for well defined and delimited 
problems. Therefore they serve to find solutions once the system is already well 
structured and all relevant requirements for all system functions are defined. This is the 
case only at the end of the whole conceptual design process as defined in sub-section 
1.6.2 and corresponds to the step 4 of the proposed methodology (sub-section 2.3.7). 
They do not address the design challenges listed in section 2.1 which require an analysis-
and-structuring-tool and not primarily a solution-finding-tool. 
 
A more comprehensive approach to the development and design of technical systems 
and products is given by the VDI standard 2221 [25]. It describes a methodology 
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that incorporates the whole design process from the definition of requirements to 
specification of the final product. It mentions the early design phases like the analysis of 
the underlying problem and the resulting definition of system requirements as well as the 
necessity to structure the primary interrelationships of the system. Nevertheless, there is 
only a rather superficial and no detailed description of these essential phases. A 
description of tools that would support these phases is missing. 
 
The aforementioned references provide methodologies that can be applied to design 
problems in general and do not take into account the specific aspects of an acoustic 
hearing implant. A literature study in the field of implantable hearing aids was conducted 
but did not provide a well developed conceptual design methodology. There are few 
articles that discuss basic requirements and design aspects of acoustic hearing implants, 
but they do not help the designer to specify requirements and to derive optimal solutions 
from them. 
 
Ko et al. [26] for example mention that medical and engineering aspects have to be 
considered. However the medical aspects are neglected and the article concentrates on 
transducer principles and their technical characteristics. Only the human ear transfer 
functions are investigated in more detail but without discussing the relation with the 
different transducer principles. 
 
Leysieffer et al. provide a detailed list of the user and system requirements of an actuator 
for acoustic hearing implants [27], [28]. This includes technical performance as well as 
medical characteristics. They further mention that the major challenge of the development 
of such an actuator is to manage partially contradictory requirements and to find the best 
compromise solutions. Even if their approach seems very complete and well investigated, 
the resulting TICA device showed an insufficient therapeutic performance. Possible 
reasons are discussed in sub-section 2.2.2. 
 
2.2.2 Analysis of Existing Acoustic Hearing Implants 
Overview 
The era of acoustic hearing implants started in the late 1970s with the use of BAHA 
devices, followed by the first implantation of the Rion E-type device in 1987. Since then, 
multiple devices were developed, manufactured and implanted. Table 2-1 gives an 
overview over the most relevant devices. Some of them are analyzed in more detail in the 
subsequent sub-sections. 
 
 
 
 
 
  21 
  
Table 2-1: Overview of existing acoustic hearing implants 
Device 
Name 
Manufac-
turer 
Implant 
Type 
Indicated 
Hearing Loss 
Coupling 
Site 
Avai-
lable 
Actuator Type 
TICA Implex fully sensorineural Incus no Piezo disc 
M.E.T. Otologics semi sensorineural Incus no Electro-
mechanic 
Carina Otologics fully sensorineural, 
mixed 
Incus, 
round 
window 
yes Electro-
mechanic 
Sound-
bridge 
MED-EL semi sensorineural, 
mixed 
Incus, 
round 
window 
yes Electro-
magnetic 
Esteem Envoy 
Medical 
fully sensorineural Stapes yes Piezo strip 
E-type Rion semi sensorineural Stapes no Piezo strip 
Direct 
Drive 
Hearing 
System 
Soundtec semi sensorineural Incudo-
stapedial 
joint 
no Electro-
magnetic 
BAHA Cochlear semi conductive, 
(mixed) 
Cranial 
bone 
yes Electro-
mechanic 
 
TICA – Totally Implantable Cochlear Amplifier from Implex 
The TICA was the first totally implantable middle ear implant [29], [30]. It consists of a 
microphone placed in the auditory canal wall, an actuator placed in the mastoid bone and 
an electronics unit implanted behind the ear, between skull and skin. The actuator is 
coupled to the incus body (Fig. 2-1). 
 
The device was CE marked in 1999 and implanted approximately 20 times [31]. There are 
two probable reasons for stopping the implantations. On the one hand, the device gain is 
very limited due to feedback between the actuator and the microphone [31]. The three 
feedback paths (acoustic, mechanic and electronic) were probably neglected or 
underestimated during the design and verification phases. Only when the device was 
implanted in its final configuration the feedback occurred. This indicates that system level 
verification was not sufficient and that the interactions between the different system 
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components as well as the interactions with the surrounding tissues were not sufficiently 
considered. 
 
On the other hand, the actuator itself (Fig. 2-2) provides a frequency response that is not 
well adjusted to the natural frequency response of the ear as shown in Fig. 2-3. The 
resonance frequency of the actuator is significantly higher than the natural resonance of 
the human ear. Therefore the actuator efficiency increases with frequency but is rather 
limited at frequencies below 1.5 kHz [31]. This unbalanced characteristic restricts the 
indication of the device to patients with high frequency hearing loss. 
 
 
Fig. 2-1:  Schematic representation of the implanted TICA system: the microphone is 
placed close to the actuator and both are anchored in the same bone [32] 
 
Titanium diaphragm
Polymer seal
Hermetic feedthrough
Piezo disc
Coupling rod
 
Fig. 2-2:  Longitudinal section through the TICA actuator, modified after [30] 
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The TICA actuator is a good example that shows how a conceptual choice limits the 
device performance without the possibility to improve it by optimization during the detailed 
design phase. As Fig. 2-3 shows, the actuator is too rigid, resulting in a too high 
resonance frequency. The selected actuation principle of a piezo-electric disc bender did 
not allow for sufficient adaptation of the design parameters. The diameter of the disc 
bender could not be further increased to decrease its rigidity because the available space 
in the mastoid bone is restricted. The thickness of the disc bender could not be decreased 
neither, due to actual limits of the piezo disc fabrication. 
 
 
Fig. 2-3:  Frequency response of the TICA actuator (continuous line) in comparison 
with the natural stapes deflection characteristic (dashed line) [30] 
 
M.E.T. / Carina from Otologics 
To date, Otologics brought two products on the market. The initial M.E.T. was a semi-
implantable device that is now replaced by the Carina, which is a fully implantable device 
[33] - [35]. Both implants are equipped with the same actuator shown in Fig. 2-4. It is 
based on a standard balanced armature actuator that is widely used for loudspeakers of 
conventional hearing aids. This balanced armature actuator is encapsulated in a hermetic 
titanium housing in order to meet the biocompatibility requirements. 
 
This conceptual approach causes a major challenge: the generated deflections have to 
be fed through the hermetic encapsulation without damping them too much. Since the 
frequency response is already given by the selected actuator, it is necessary to minimize 
the impact of the encapsulation. The technical solution consists of a sophisticated bellows 
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structure (Fig. 2-4) which is characterized by a high compliance. The fabrication of such a 
thin bellows structure is a technological challenge that is difficult to cope with. 
Consequently, the first generation of implanted actuators became leaky after a while 
because the bellows started to disintegrate. 
 
Coil
Feedthrough
Coupling
rod
Armature
Bellows
Lead
Magnets and
soft magnetic
structure
 
Fig. 2-4:  Longitudinal section through the Carina actuator, modified after [36] 
 
This is another example that shows the consequence of conceptual decisions. The 
decision to use an existing actuator technology that was initially designed for another 
application forced the engineers to find an almost impossible compromise between 
hermeticity, compliance and reliability for the encapsulation. Instead of looking for an 
integrated solution considering encapsulation and actuator, all the demanding 
requirements were put on the encapsulation side. 
 
The patient selection criteria shown in Fig. 2-5 indicate two more implications of the 
device concept on the device performance. One can observe that the semi-implantable 
device is indicated for patient with more severe hearing loss than the fully implantable 
device. One reason is probably a more limited gain of the fully implantable device due to 
feedback between the actuator and the implanted microphone (like TICA). Further, the 
device amplification seems to be lower at low frequencies than at higher ones. This 
indicates that the frequency response of the actuator is not well adapted to the natural 
frequency response of the human ear (cf. TICA). The probable reason is the same as for 
the hermeticity problem, namely the bellows encapsulation. The additional rigidity of the 
bellows (even if it was minimized) caused a frequency response with increased 
resonance frequency. 
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Fig. 2-5:  Patient selection criteria for the semi and fully implantable Otologics device 
[37], [38] 
 
Vibrant Soundbridge from MED-EL 
The Vibrant Soundbridge proposes another solution for the dilemma between hermetic, 
biocompatible encapsulation and the transmission of the actuator deflections. The 
actuator principle is based on mass inertia. Fig. 2-6 shows the actuator from the outside 
and inside. Within the rigid actuator housing there is a magnet suspended in between two 
elastic elements. If current runs through the coils, an axial force is applied on the magnet 
causing the corresponding reaction force on the actuator housing. Since this actuator is 
directly clipped on the incus, the reaction force deflects the whole ossicular chain [39] - 
[41].  
 
Two-core lead with straight wires
Elastic elements
Coils
Magnet
 
Fig. 2-6:  Vibrant Soundbridge actuator: outside and inside view, modified after [42] 
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The drawback of this concept is its frequency response as shown in Fig. 2-7. The actuator 
deflections below 1 kHz and above 6 kHz drop down in comparison with the human ear 
characteristic. 
 
 
Fig. 2-7:  Frequency response of the Vibrant Soundbridge actuator (red line) in 
comparison with the natural stapes deflection characteristic (blue lines) [42] 
 
Another issue that concerned the first device generation was the breakage of the lead 
wires. As shown in Fig. 2-6 the lead consisted of two very thin, straight gold wires. Since 
the lead passes between the cranial bone and the above tissues that include muscle 
tissue, it is constantly subject to small displacements due to muscle contractions. The 
straight wires did not provide any strain relief and broke after a while due to fatigue. This 
shows, as already observed with the TICA device, that it is important to consider all the 
surrounding tissues and to consider all the corresponding interactions. 
 
Esteem from Envoy Medical 
The Esteem from Envoy Medical is the most recent device on the market. The fully 
implantable system (Fig. 2-8) distinguishes itself by several new concepts. For instance it 
does not contain an air microphone but a piezo-electric transducer that captures the 
movements of the malleus. To prevent the feedback loop between the sensor coupled to 
the malleus and the actuator coupled to the stapes, the ossicular chain has to be 
surgically interrupted. Further the device is equipped with a non-rechargeable battery 
which prevents any maintenance of the system for up to nine years, as promised by the 
manufacturer.  
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Fig. 2-8:  Esteem implant with magnified representation of the sensor and the actuator 
[32] 
 
Unfortunately there is almost no technical data published so far, what makes it difficult to 
analyze the device. Nevertheless it is possible to draw some conclusions from the 
published clinical data. The patient selection criterion (Fig. 2-9), for example, shows that 
the device amplification is rather low below 1 kHz and increases at higher frequencies. 
This characteristic is very similar to the one of the TICA device and indicates as well that 
the actuator provides a frequency response that differs from the normal ear. Therefore the 
use of the device is restricted to patients with the corresponding hearing loss 
characteristic. 
 
 
Fig. 2-9:  Patient selection criterion for the Esteem device [32] 
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A further weakness of the device seems to be its reliability. The results of the phase I 
clinical trial show that from seven patients only three benefited from the device [43]. Three 
devices even required replacement of all system components by revision surgeries. Due 
to absence of corresponding data it is not possible to name reasons for the device 
failures. However it is possible to draw one general conclusion for the development of 
implantable devices: one of the most important verification aspects is the reliability of the 
device. The verification tests should clearly demonstrate that a device can withstand the 
implant specific environments and operate for the specified life time prior to first human 
implantation. This requires that all user requirements and system environments are 
sufficiently understood to determine valid system requirements, which are the basis for a 
successful verification. 
 
2.2.3 Summary of Extracted Design Methodology Requirements  
The list of requirements for the conceptual design methodology from section 2.1 can be 
completed with the following aspects: 
? The analysis of the existing devices highlights again the importance of the 
system requirements. Since they are the basis for the device verification prior to 
validation in patients, they have to cover all relevant aspects of the device. This 
requires a profound understanding of the user requirements and the system 
environments. 
? It is necessary to understand all interactions between the different system 
components (or functions) as well as the interactions between the system 
components and the system environments. Otherwise it is not possible to find 
integrated solutions that represent a system optimum. One interaction that 
seems of particular importance is the influence of the encapsulation on the 
actuator characteristics. All of the analyzed devices provide compromise 
solutions with specific disadvantages. 
? The system should be designed in response to the user requirements and not 
be based on some preferred technology. Every system function should be 
derived from the user requirements and not vice versa. 
 
2.3 Proposed Methodology 
2.3.1 Introduction 
Multiple requirements are defined in section 2.1 and sub-section 2.2.3 with regard to the 
methodology content. In order to meet these requirements it is proposed to additionally 
base the methodology on the following formal requirements: 
? The methodology shall include a graphical representation of the system and its 
environments. This enables a good overview and inclusion of details by hiding 
(but not removing) non-relevant information, similar to a mind map. 
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? The methodology shall follow of the V-model, by cumulating the information 
from the determination of the user requirements down to the conceptual design. 
 
Fig. 2-10 shows an overview of the resulting conceptual design methodology. It consists 
of a step-by-step procedure and a diagram tool. 
 
Conceptual Design 
Methodology
Inputs Outputs
Therapy goal
Given stakeholder 
requirements
User 
requirementsProcedure
Diagram tool
System 
requirements
Conceptual 
design  
Fig. 2-10:  Conceptual design methodology overview  
 
The diagram tool is presented in the following sub-sections: 
? Sub-section 2.3.2 introduces the symbols used for graphical representation of 
the system and defines the specific terms. 
? Sub-section 2.3.3 defines how the graphic representation of the system can be 
re-structured in order to approach an optimal system concept. 
 
The procedure is described by applying the methodology to design the DACS system or 
parts of it. The necessary design inputs (therapy goal and stakeholder requirements) are 
very restricted, since the determination of most of the requirements is part of the 
methodology. In this case of the design of the DACS system the following design inputs 
are considered: 
? The system shall successfully treat patients with severe to profound mixed 
hearing loss. 
? The system shall consist of an external part based on a modified conventional 
hearing aid, a link through the skin and an implantable part that contains an 
actuator and a fixation system. 
? The coupling of the actuator to the cochlea shall be established with a stapes 
prosthesis that is placed like during a conventional stapedectomy. 
 
The four procedure steps are presented in the following sub-sections: 
? Sub-section 2.3.4 presents the first of four steps of the actual methodology. It 
consists in analyzing the human ear and deriving the functions that shall be 
emulated by the system. 
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? Sub-section 2.3.5 describes the second step that consists in transforming the 
previously defined functional diagram of the ear into a system diagram. This 
helps to get a first idea of the architecture and the main functions of the future 
system. 
? Sub-section 2.3.6 includes the third step. This central step describes how to 
determine the user requirements and how they are translated into system 
requirements. 
? Section 2.3.7 presents the fourth step that consists in working out the 
conceptual system design. This means that a solution for each function has to 
be found that responds to determined interfaces.  
 
The final question will be how useful and efficient the proposed methodology is. The 
answer can only be given indirectly, based on resulting device characteristics. Only the 
validation of the therapeutic performance of the final device indicates if the concept is 
appropriate or not. The corresponding discussion is part of section 5.3. 
 
2.3.2 Definition of Terms and Corresponding Diagram Symbols 
Function / Sub-function 
A function or sub-function (Fig. 2-11) is the central element of the proposed methodology. 
The to-be-designed system is represented by a multitude of functions and sub-functions 
that are interlinked through interfaces. Initially the functions and sub-functions are 
considered as “black boxes” that are only characterized by their interfaces which specify 
their input and output quantities. The final goal will be to find a solution for each function 
and sub-function that provides the specified output quantity depending on the input 
quantity. 
 
Function Name
F1
Function Name F2
Sub-function Name
F2.2
 
Fig. 2-11:  Graphic symbols for functions and sub-functions 
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In general a function or sub-function has at least one interface that links it to a global 
environment or another function or sub-function. It is proposed to subdivide the identifier 
of the function in order to label the sub-function. 
 
A function or sub-function is represented as box with rounded corners and is labeled with 
function or sub-function name and identifier (Fx and Fx.x). 
 
System / Sub-system 
A system or sub-system (Fig. 2-12) serves two purposes. On the one hand it helps 
structuring the system by grouping functions together. This allows to simplify the 
representation of the diagram by replacing complex function networks by just the system 
box (cf. local environment). On the other hand it serves to apply global interfaces. In 
general systems or sub-systems are directly related to the physical architecture of the 
device that is designed. 
 
System Name S1
Sub-system Name
S1.1
Sub-system Name
S1.2
 
Fig. 2-12:  Graphic symbols for systems and sub-systems 
 
A system or sub-system is represented as a box with rounded corners. It is labeled with 
the system name and identifier (Sx and Sx.x). It is proposed to subdivide the identifier of 
the system in order to label the sub-systems. 
 
Global Environment 
A global environment (Fig. 2-13) represents an environment that influences a system or 
interacts with it. This can be a concrete physical object like a body tissue as well as a 
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project stakeholder or a regulatory authority. The global environments determine the 
system requirements. 
 
In contrast to a local environment, a global environment is not part of the to-be-designed 
system. 
 
A global environment is represented as an oval box placed around a system. The box is 
labeled with the name of the global environment and the corresponding identifier (Ex). 
 
System Name
S1
Environment Name
E1
Environment Name
E2
Environment Name
E3
 
Fig. 2-13:  Graphic symbols for global environments 
 
Local Environment 
A local environment (Fig. 2-14) is a term introduced to designate a sub-system, function 
or sub-function seen from the perspective of a function or sub-function. This allows 
representing a specific function or sub-function with its whole context in a clearly arranged 
way (as it will be shown in sub-section 2.3.3). 
 
Function Name
F1
Environment Name
E1
Function Name
F2 Environment Name
E2
Sub-system Name
S1.2
 
Fig. 2-14: Function F2 and sub-system S1.2 are local environments of function F1 
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There is no dedicated symbol for a local environment, since it is represented by the 
corresponding sub-system, function or sub-function symbol. 
 
Interfaces 
A function is specified by its interfaces. The characteristics of the interfaces specify the 
input quantities, the output quantities and any other requirement to which the function has 
to comply. There are two distinct types of interfaces: 
 
Sub-function Name
F1.1
Function Name
F2
I2
I1
Sub-function Name
F1.1
Function Name
F2
Sub-system Name
S1.2
System Name S1
I3
I4
I2
I1
 
Fig. 2-15:  Graphic symbols for global (left) and local (right) interfaces 
 
Global Interface: 
A global interface (Fig. 2-15) “encases” a whole system, sub-system, function or sub-
function, meaning that the global interface applies to every encased sub-element. If a 
system, sub-system, function or sub-function is split into corresponding sub-elements, the 
global interface has to be applied to each of them. (cf. sub-section 2.3.3, Splitting of 
functions) 
 
Global interfaces provide general requirements that have to be met by the system, sub-
system, function or sub-function like a temperature range or a weight. Thus every sub-
element has to contribute in order to meet the requirement.  
 
A global interface is represented as a simple box labeled with its identifier (Ix) which is 
placed adjacent to the edge of a system, sub-system, function or sub-function box. 
 
Local Interface: 
A local interface (Fig. 2-15) can be considered as a “port” (input or output) in order to 
exchange a quantity with a function, sub-function or environment. If a function or sub-
function is split into corresponding sub-elements, a new local interface has to be defined 
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in between in order to link the original local interfaces. (cf. sub-section 2.3.3, Splitting of 
functions) 
 
Local interfaces specify input and output quantities like sound pressure or force. Thus, if 
the conversion from sound pressure to force is done in several steps, the intermediate 
quantities have to be attributed to intermediate local interfaces. 
 
A local interface is represented as a simple box labeled with its identifier (Ix) which is 
placed overlapping the edge of a function or sub-function box. 
 
2.3.3 Definition of Diagram Drawing Rules 
Interfaces between functions 
There are two equivalent possibilities to draw the interface between two functions (Fig. 
2-16). Either one interface box is common for both functions, or two interface boxes are 
interlinked with a line. The possibility that is more appropriate to the diagram can be freely 
chosen. 
 
Function
F1
Function
F3
Function
F4
Function
F2I1
I2
I2
 
Fig. 2-16: Two possibilities to represent an interface between two functions 
 
Splitting of functions 
A function F1 can be split into two or more functions (e.g. F2 to F6) by introducing 
corresponding intermediate interfaces (I4 to I8). Any global interface I3 of the original 
function F1 has to be applied on each of the new functions F2 to F6. These new global 
interfaces may have individual characteristics according to related functions and are 
therefore individually named I9 to I13 (Fig. 2-17). 
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Function
F2
Function
F3I4I4
I10I9
Function
F1I1 I2
I3
I1
Function
F5
Function
F4 Function
F6
I5
I7I7 I8I8
I2
I6I6
I11 I12
I13
 
Fig. 2-17: Function F1 is split into functions F1 to F5 
 
Determination of sub-functions 
A function F1 can be subdivided into multiple sub-functions F1.1 and F1.2 while 
respecting the original interfaces I1, I2 and I3 (Fig. 2-18). An interface I4 is introduced to 
link the two sub-functions F1.1 and F1.2 and to maintain the link between I1 and I2. 
 
Function
F1I1
Function F1
Function
F1.2
Function
F1.1
I2
I1 I4I4 I2
I3
I3
 
Fig. 2-18: Function F1 is decomposed into sub-functions F1.1 and F1.2 
 
Decoupling from a global interface 
It might be very difficult to find a solution for the function F1 that meets all requirements 
imposed by the global interface I3. Therefore it could be interesting to eliminate the 
influence of the global interface I3 by adding a function F2 that decouples the original 
function F1 from the global interface I3 (Fig. 2-19). Thereto all local interfaces I1 and I2 of 
the original function F1 have to be passed through the added function F2. In this way it is 
guaranteed that the global interface I3 stays considered when specifying the local 
interfaces I1 and I2. 
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Function
F2
Function
F1
Function
F1
I3
I1
I1
I2
I3
I1 I2
I2
I1 I2
 
Fig. 2-19: Function F1 is decoupled from interface I3 by introducing F2 
 
Isolating a function 
Once the system diagram is drawn, one has to start searching for solutions for all the 
functions. In this situation it is advantageous to concentrate on one single function at the 
time (e.g., F2), but without missing any element that has to be considered. Thereto it is 
possible to isolate a function F2 by considering all local environments (function F1) and 
global environments (E2 and E4) that are link to it (Fig. 2-20). 
 
Environment
E1
System S1
Function
F2
Function
F1
Function
F3
Environment
E3
Environment
E2
Environment
E4I2
I2
I5
I1
I3
I4
Function
F2I2 I3
Environment
E2 I5
Function
F1
Environment
E4
 
Fig. 2-20: Function F2 is isolated from the system and represented with its global and 
local environments 
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2.3.4 Step 1: Determination and Analysis of Human Body Functions that 
Shall Be Emulated by the System 
This step builds the basis for the future system. It determines which body functions will be 
taken over by the system. The more accurately this body functions will be emulated by 
the system, the bigger the patient benefit. Therefore it is of great importance to analyze 
this body functions in detail in order to determine the corresponding system requirements. 
 
Step 1.a: Determination of human body functions 
The human body functions that shall be emulated by the system have to be determined. 
These can be physiological as well as anatomical. Each function is placed into the system 
diagram. 
 
At this stage the very basic concept of the future system has to be known. In the present 
case it is decided to just emulate the “sound conversion” of the ear, meaning that the 
single primary function of the “representative ear” is capturing sound, transforming it into 
a mechanical vibration and providing this vibration to the cochlea (DACS approach as 
explained in sub-section 1.5.2). The corresponding diagram is very simple (Fig. 2-21). As 
shown above it consists of the sound conversion function F1 that is part of the 
representative ear system S1. 
 
Representative Ear S1
Sound conversion
F1
 
Fig. 2-21:  Considered function of the representative ear 
 
Step 1.b: Determination global environments 
Every global environment that is either related to one of the functions or to the whole 
system has to be determined. 
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Three global environments are determined for the representative ear system: the sound 
environment E1, the cochlea E2 and the surrounding temporal bone E3 as shown in Fig. 
2-22. 
 
Sound
environment
E1
Representative Ear S1
Sound conversion
F1
Temporal bone
E3
Cochlea
E2
 
Fig. 2-22:  The global environments of the representative ear 
 
Step 1.c: Attribution of interfaces 
Now the global environments have to be linked to the system and its functions (Fig. 2-23). 
It is important to attribute the correct type of interface, either local or global ones. 
 
The sound environment E1 provides the system input, namely sound pressure. It is 
captured by the sound conversion function F1 resulting into the corresponding local 
interface I1. 
 
The cochlea E2 receives the system output, namely a mechanical vibration. The sound 
conversion function is therefore linked to the cochlea E2 by the local interface I2. 
 
The temporal bone E3 surrounds the representative ear S1 and interfaces with it as a 
whole. Therefore a global interface I3 is attributed between E3 and S1. This means that 
the sound conversion function F1 is linked to the temporal bone E3 as well. 
 
Sound
environment
E1
Representative Ear S1
Sound conversion
F1
Temporal bone
E3
Cochlea
E2I2I1
I3
 
Fig. 2-23:  Determination of system interfaces 
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The interactions of the temporal bone with natural human ear are numerous. The 
temporal bone provides mechanical protection of the sensible ear structures, blood 
irrigation, mechanical anchorage of the middle ear ossicles and so on. Representative for 
the future implant is only the anchoring function. Therefore an anchoring function F2 is 
explicitly introduced in the diagram of the representative ear S1 (Fig. 2-24). The interfaces 
I3 and I4 have local character on F2 side, since the anchoring function transmits a force 
from the temporal bone E3 to the sound conversion F1 and vice versa. I4 is a global 
interface of the sound conversion F1 because the anchoring function F2 has to stay 
linked to every sub-element of F1. 
 
Sound
environment
E1
Representative Ear S1
Sound conversion
F1
Temporal bone
E3
Cochlea
E2I2I1
Anchoring
F2
I4
I3 I4
 
Fig. 2-24:  System diagram that represents to the body functions that shall be emulated 
by the acoustic hearing implant 
 
Step 1.d: Characterization of the system elements 
Global environments: 
The system characterization starts with the characterization of the global environments. 
For each of them it has to be analyzed how exactly they interact with the system. The 
following characteristics have to be determined for each environment: 
? Which quantities are exchanged with the system? 
? In which ranges vary these quantities? 
? Which requirements are imposed by the environment? 
 
Sound environment E1: 
Fig. 2-25 shows which sounds are perceived by the human ear from the hearing threshold 
up to the pain threshold. One can observe that an equally perceived loudness (Phon 
curves) does not correspond to an equal sound pressure level through all frequencies. 
Loudness and sound pressure are only aligned at 1 kHz by definition. The sensibility of 
the ear decreases towards the low and the high frequencies. Any sound between the 
threshold of audibility and pain threshold has to be considered as system input. 
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Fig. 2-25:  Hearing (dashed curve) and pain thresholds (red curve) in the human, the 
“Phon curves” correspond to equally perceived loudness according to [44] 
 
Cochlea E2: 
The stapes generates a pressure wave that is propagated in the cochlea and causes 
deflection of the basilar membrane. The movements of the stapes have a specific 
frequency characteristic as shown in Fig. 2-26. If a constant sound pressure is applied in 
front of the tympanic membrane, the stapes velocity increases with approximately 20 dB 
per decade until 1 kHz, then it decreases with approximately 20 dB per decade. 
 
Temporal bone E3: 
The temporal bone is a very hard bone that surrounds the whole hearing organ. Since it is 
only considered for anchoring, there are no other characteristics to consider than the 
mechanical properties of bones. 
 
Interfaces: 
These interfaces are body tissues that have to be replaced later on by some technologies 
(see step 2). Therefore their characteristics are important to know: 
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? What is the bandwidth of the interface? 
? Is the interface structure related to other functions that are not considered for 
the system? 
 
I1: 
The interface between the sound environment E1 and the sound conversion function F1 
is the tympanic membrane. It converts the sound pressure into a mechanical movement. 
Its bandwidth and dynamic range correspond to the values given for E1. 
 
I2: 
The oval window is the interface between the sound conversion function S1 and the 
cochlea E2. The stapes footplate closes the oval window and is elastically suspended 
with an annular ligament. The corresponding dynamic characteristic is shown in Fig. 2-26. 
 
 
Fig. 2-26:  Normalized middle ear transfer function at 94 dB SPL in front of the tympanic 
membrane according to ASTM F2504-05 [45] 
 
I3 and I4: 
There are multiple interfaces between the temporal bone tissue and the anchoring 
structures (ligaments, muscles with tendons) as well as between the anchoring structures 
and the sound conversion elements (tympanic membrane, middle ear ossicles). In the 
natural ear these anchoring structures do contribute to the sound conversion function 
since they elastically suspend the middle ear ossicles. In the future acoustic hearing 
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implant there will be a strict separation between sound conversion function and anchoring 
function. Therefore the detailed mechanical properties of the ligaments and tendons are 
not of interest. 
 
Functions: 
The functions stay black boxes at this stage. The search for dedicated solutions will be 
done in a subsequent step (step 4). 
 
2.3.5 Step 2: Determination of Preliminary System Architecture 
After having determined the human body functions that have to be emulated by the 
system and drawn the corresponding representative ear diagram, the diagram has to be 
transformed into the future acoustic hearing implant system diagram. At this stage it is 
useful to adapt the diagram to the already known elements of the system architecture. 
This eliminates variables and prepares the system diagram for the step 3. Fig. 2-27 
summarizes all the modifications of the diagram of the representative ear system in order 
to obtain a basic diagram of the acoustic hearing implant system. The individual 
modification steps are explained below. 
 
Acoustic Hearing Implant S1
External Part S1.1 Implanted Part S1.2
Sound
environment
E1
Temporal bone
E3
Cochlea
E2Sound reception
F1.1.1
Signal processing
F1.1.2
Signal & energy
transfer F1.1.3
Generation of vibrations
F1.3
Signal & energy
reception F1.2
Anchoring
F2.1
I1 I5
I5I6
I6 I7
I7
I8
I8
I2
Anchoring
F2.2
Head
E4
I4
I4
I9
I3
Hearing Implant S1.2.1
Fixation System S1.2.2
I10
I10
Sound treatment F1.1
 
Fig. 2-27:  Basic diagram of the acoustic hearing implant 
 
It is required that the acoustic hearing implant is a semi-implantable device consisting of 
an externally worn audio processor, a signal and energy transmission through the skin 
and an implanted actuator (sub-section 2.3.1). The implanted actuator will be hold in 
place with a “fixation system” – a mechanical mounting structure that anchors the actuator 
to the temporal bone. Therefore the following sub-systems are introduced: 
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? External Part S1.1 
? Implanted Part S1.2 
o Hearing Implant S1.2.1 
o Fixation System S1.2.2 
 
In a second step, the sound conversion function F1 has to be split in multiple serial 
functions in order to respect the above defined sub-systems: 
? Sound treatment F1.1 
o Sound reception F1.1.1 
o Signal processing F1.1.2 
o Signal & energy transfer F1.1.3 
? Signal & energy reception F1.2 
? Generation of vibrations F1.3 
The signal treatment function F1.1 is part of the external part S1.1 while F1.2 and F1.3 
are parts of the implanted part S1.2. 
 
The anchoring function F2 has to be split as well. Since the temporal bone E3 is not an 
environment of the external part S1.1, a corresponding, new environment and anchoring 
function has to be introduced. The global environment head E4 takes over the role of the 
temporal bone E3 for the anchoring function F2.2 of the external part S1.1. 
 
It can be observed that the initial structure of the representative ear diagram is not 
changed. All the initial environments, interfaces and functions still exist. The global 
environments and their interfaces stayed unchanged beside the introduction of the new 
global environment E4. 
 
Things that do change are the characteristics of the interfaces towards the global 
environments. These interfaces are no longer body tissues but have to be transformed 
into technical equivalents. This will be part of the conceptual design step (step 4). 
 
2.3.6 Step 3: Determination User and System Requirements 
This is a central step that determines the requirements of the acoustic hearing implant. 
These requirements are partially given by the already determined environments of the 
representative ear and are completed by introducing “artificial” environments. They cover 
everything that influences the system or interacts with it. They can have direct impact on 
the primary function of the system like the hearing loss of the patient or influence the 
system as a whole like the transport conditions. 
 
This design step is demonstrated by applying it only to the implantable part S1.2 of the 
acoustic hearing implant S1. This shows an important property of the diagram 
methodology, namely the possibility to isolate a sub-system or function from the complete 
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system without the risk of neglecting something important. The implanted part S1.2 and 
the exemplarily added artificial environments E5 to E10 are shown in Fig. 2-28. The 
external part S1.1 is represented as a local environment, so it is still considered. 
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Surgeon
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Transport
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E8
Packaging
E7
Storage
conditions
E9
Implant
conditions
E5
Implanted Part S1.2
Temporal bone
E3
Cochlea
E2
Generation of vibrations
F1.3
Signal & energy
reception F1.2
Anchoring
F2.1
I7
I8
I8
I2
I4
I4 I3
Hearing Implant S1.2.1
Fixation System S1.2.2
I16
I14
I13
I12I11
Hearing loss
E10 I15
 
Fig. 2-28:  Implanted Part S1.2 with all environments 
 
External part S1.1: 
It is assumed that the system electronics including the sound reception F1.1.1, the sound 
processing F1.1.2 and the signal & energy transfer F1.1.3 provide completely linear 
transfer functions as long as no individual hearing loss is programmed. This means that 
the output signal, which is provided by S1.1, is strictly proportional to the captured sound 
pressure. Therefore the provided signals correspond to Fig. 2-25 with one exception: the 
conventional hearing aid that serves as basis for the external part S1.1 limits the system 
bandwidth to 125 Hz – 8’000 Hz. 
 
The energy provided by the external part S1.1 is limited as well. The device has to 
operate at least one day without changing the battery. Based on the energy budget of the 
whole system, this entails that the output power of S1.1 is restricted to 1 mW. This results 
in the following requirements (user requirements are abbreviated by UR and the derived 
system requirements by SR): 
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Table 2-2: User requirements related to the external device part S1.1 
N° Description Comment 
UR 1 The system shall not consume more power than the 
capacity of a type 13 battery per day 
 
UR 2 The system shall be able to process any sound signal 
between hearing and pain thresholds and between 
125 Hz and 8’000 Hz 
 
 
Table 2-3: System requirements derived from the user requirement in Table 2-2 
N° Description Value Comment 
SR 1.1 The hearing implant input 
power is 
 1 mW Based on system power 
budget 
SR 1.2 The hearing implant impedance 
at 37°C shall be 
44 Ω ± 3 
7.5 mH ± 1.5 
In order to match the 
electronics output of the 
external part 
SR 2.1 The hearing implant input 
dynamic shall be 
 125 dB  
SR 2.2 The hearing implant input 
bandwidth shall be 
100 Hz to 
10’000 Hz 
This is above the user 
requirement in order to 
not limit the system and 
allow for updates of the 
external part 
 
Cochlea E2: 
The natural stimulus of the cochlea has a special characteristic shown in Fig. 2-26. The 
system has to provide a similar output characteristic to emulate as far as possible the 
natural hearing. 
 
Table 2-4: User requirements related to the environment E2 
N° Description Comment 
UR 3 The actuator shall provide a transfer function that 
emulates the frequency characteristic of the human 
middle ear 
 
UR 4 The mechanical output structure of the system shall be 
similar to a human incus and allow for the attachment of 
commercially available stapes prostheses 
Cf. sub-section 
1.5.2 
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Table 2-5: System requirements derived from the user requirement in Table 2-4 
N° Description Value Comment 
SR 3.1 The hearing implant transfer function shall 
provide a resonance frequency close to 
1 kHz 
SR 3.2 The slope of the hearing implant transfer 
function below resonance frequency shall 
be close to  
20 dB 
((m/s)/V) 
SR 3.3 The slope of the hearing implant transfer 
function above resonance frequency shall 
be close to 
-20 dB 
((m/s)/V) 
Based on 
ASTM 
F2504-05, 
cf. Fig. 
2-26 
SR 4.1 The diameter of the artificial incus shall be 0.9 mm ± 0.3  
SR 4.2 The length of the artificial incus shall be 1.5 mm ± 0.5  
 
Temporal bone E3: 
The hearing implant S1.2.1 will be anchored to the temporal bone by the fixation system 
S1.2.2. This fixation has to hold the system securely in place even if the head of the 
patient is exposed to high accelerations (car accident, bang one’s head). 
 
Table 2-6: User requirements related to the environment E3 
N° Description Comment 
UR 5 The hearing implant shall be firmly anchored in the 
temporal bone even in case of accidental accelerations 
 
 
Table 2-7: System requirements derived from the user requirement in Table 2-6 
N° Description Value Comment 
SR 5.1 The fixation system shall withstand 
accelerations of 
 100 
m/s2 
Lethal 
acceleration 
 
Implant conditions E5: 
The fact that the implanted part S1.2 is placed in the human body for the long term 
causes numerous requirements which include the important safety and reliability aspects 
of an active implantable medical device. Most of these requirements are specified in 
standards like EN45502-1 (active implantable medical devices) and ISO10993 
(biocompatibility). The main aspects regarding the biocompatibility are: 
? Toxicity 
? Surface texture 
? Sterility 
? Electrical currents 
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On the other side the implant itself has to withstand the conditions in the human body 
which represents a humid and corrosive environment. 
 
A further important aspect of the implant conditions concerns the size and shape of the 
implanted part. Implant size and shape are closely related to the human anatomy and the 
adopted surgical procedure. In the present case, the corresponding system requirements 
are empirically assessed by multiple implantation trials on head preparations. 
 
Table 2-8: User requirements related to the environment E5 
N° Description Comment 
UR 6 The implanted part shall be reliable and safe during 
the whole duration of the clinical trial 
 
UR 7 The implanted part shall be biocompatible 
(implantable for the long term) 
 
UR 8 The implanted part shall be sterilizable  
UR 9 The implanted part shall be implantable in most of the 
adult population 
 
 
Table 2-9: System requirements derived from the user requirement in Table 2-8 
N° Description Value Comment 
SR 6.1 The life time of the implanted part shall 
be 
 2 years  
SR 6.2 The implanted part shall withstand 
vibrations of 0.1 g2/Hz according to 
test procedure described in EN60068-
2-47 
0.1 g2/Hz, 
90 min 
EN45502-1 section 
23.2 
SR 6.3 The DC current that is delivered to 
human tissue shall be 
 1 μA EN45502-1 section 
16.2 
SR 6.4 The temperature at the implant surface 
shall not exceed the tissue 
temperature by more than  
 2°C EN45502-1 section 
17.1 
SR 7.1 The materials in contact with human 
tissue shall have proven 
biocompatibility records 
Ti 
Silicone 
Pt 
Pt-Ir 
 
 
 
SR 7.2 Any other material shall be 
hermetically encapsulated, the He leak 
rate shall be 
 5·108 
mbar·l/s 
MIL-STD-883E 
SR 7.3 The implant shall not have any sharp 
edges, edge radii shall be 
 0.5 mm  
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N° Description Value Comment 
SR 7.4 The general hearing implant shape 
shall be 
convex Any open cavity 
that is not 
accessible by body 
tissue would 
increase the risk of 
chronic infections 
SR 8.1 The implanted part shall be sterilizable 
by 
ETO Ethylene oxide, 
other sterilization 
methods are 
excluded 
SR 9.1 The general actuator shape shall be cylindrical 
SR 9.2 The length of the actuator shall be  14 mm 
SR 9.3 The outer diameter of the actuator 
shall be 
 3.6 mm 
Assessed with 
implantation trials 
 
Surgeon E6: 
The implant has to be manipulated and placed by a surgeon. This requires that the device 
withstands all intended manipulations and provides the good usability (ISO62366). 
 
Table 2-10: User requirements related to the environment E6 
N° Description Comment 
UR 10 The implanted part shall withstand the intended 
manipulation during implantation 
Attaching the 
stapes prosthesis 
shall not damage 
the actuator 
 
Table 2-11: System requirements derived from the user requirement in Table 2-10 
N° Description Value Comment 
SR 10.1 The actuator shall withstand axial 
forces applied to the mechanical output 
structure of 
  200 mN 
SR 10.2 The actuator shall withstand radial 
forces applied to the mechanical output 
structure of 
  200 mN 
Empirically 
assessed 
maximal 
manipulation 
forces 
 
Packaging E7: 
The hearing implant has to be packaged what may require special characteristics. In this 
particular case the device has to be fixed in the packaging which requires a dedicated 
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interface. Since the packing will be designed in accordance to the implant and not vice 
versa, there are no additional requirements for the implanted part.  
 
Transport conditions E8 and storage conditions E9: 
The minimal requirements regarding the transport and storage conditions are specified in 
EN45502-1 and include temperature, pressure, humidity, vibration and shock. 
 
Table 2-12: User requirements related to the environment E9 
N° Description Comment 
UR 11 The implanted part shall stay functional after 
transport and storage 
 
 
Table 2-13: System requirements derived from the user requirement in Table 2-12 
N° Description Value Comment 
SR 11.1 The actuator shall withstand low 
pressures 
70 kPa 
± 5% 
SR 11.2 The actuator shall withstand high 
pressures 
150 kPa 
± 5% 
EN45502-1 section 
25.1 
SR 11.3 The actuator shall withstand low 
temperatures 
-10 °C 
± 3 
SR 11.4 The actuator shall withstand high 
temperatures 
55 °C ± 2 
EN45502-1 section 
26.2 
 
Hearing loss E10: 
This is the most important aspect of the acoustic hearing implant as it determines the 
necessary output power in order to successfully treat severe to profound mixed hearing 
loss. Since the sensorineural component of the described hearing loss is considerable (up 
to 90 dB), the efficiency of the hearing implant has to be sufficient to provide high 
maximal output power with 1 mW input (cf. SR 1.1). High output power means that the 
device has to reach the pain threshold of 125 dB SPL (Fig. 2-25) within the whole 
frequency range. This assures that there is sufficient output to treat any patient 
independently from the specific frequency profile of his/her hearing loss. This is a 
considerable challenge as observed by analyzing the existing hearing implants (sub-
section 2.2.2). None of them is able to provide such high stimulation levels at low 
frequencies. However, the device has to deliver high outputs exactly in the low frequency 
range in order to be efficient. As shown in Fig. 2-25, the hearing thresholds increase 
towards the low frequencies and require an “additional” output power of more about 20 dB 
at 100 Hz.  
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Table 2-14: User requirements related to the environment E10 
N° Description Comment 
UR 12 The hearing implant shall provided sufficient output 
power to successfully treat patients with severe to 
profound mixed hearing loss 
 
 
Table 2-15: System requirements derived from the user requirement in Table 2-14 
N° Description Value Comment 
SR 12.1 The hearing implant output bandwidth 
shall be 
100 Hz to 
10’000 Hz 
 
SR 12.2 The hearing implant output power shall 
be equivalent to 
 125 dB 
SPL 
With 1 mW input 
power (SR ) 
 
2.3.7 Step 4: Conceptual Design 
In principle the system is fully determined in step 3, and one can start searching for 
solutions for the individual functions. However, it is possible to first modify the system 
diagram in order to simplify the search for solutions process. This is demonstrated using 
the generation of vibrations function F1.3. Since the actual search for solutions process is 
outside the scope of this work, it is only presented for exemplary purpose. Any other 
search for solutions method like brainstorming, literature search, design catalogues or 
Triz can be applied as well. Here, it shall be established how the system diagram can 
support and guide the search for process. 
 
The function F1.3 is isolated from the remaining system as shown in Fig. 2-29. A 
preliminary evaluation of the influence of the different environments is done to simplify the 
task. The goal is to temporarily neglect environments that do not influence significantly 
the solution of the function. Of course, the assumption that the influence is not significant 
has to be verified once a solution is found. In the concrete case, the global environments 
E6 to E9 and the local environment S1.2.2 are put aside. From the considered ones, the 
biocompatibility aspect of the implant condition environment causes difficulties to find a 
solution. Therefore it is proposed to first decouple the function F1.3 from the environment 
E5 by adding a hermetic housing function F1.4 as shown in Fig. 2-30. Further 
modifications of the system diagram are the introduction of the stapes prosthesis 
environment E11 and the artificial incus function F1.5. This last two modifications account 
for the fact that a stapes prosthesis is used to couple the vibrations to the cochlea (sub-
section 1.5.2). 
 
As a general approach it is proposed to always proceed from the defined towards the 
undefined. This guaranties that already determined system elements are considered and 
prevents the development of incompatible solutions. Therefore following sequence is 
proposed: 
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Fig. 2-29:  Isolated generation of vibrations function F1.3 with its local and global 
environments, the elements that have to be considered further on are gray 
shaded, the white ones can currently be neglected 
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Fig. 2-30:  Generation of vibrations function F1.3 that is decoupled from the implant 
conditions environment E5 by the added hermetic housing function F1.4 
 
Artificial incus function F1.5: 
The mechanical output structure of the actuator has to provide a geometry similar to the 
long process of incus (SR 4.1and SR 4.2) in order to allow the attachment of a stapes 
prosthesis (I18). 
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Hermetic housing function F1.4: 
In order to meet the requirements coming from the implant condition environment E5, the 
actuator has to be encapsulated in a hermetic housing with the following characteristics: 
? It has to consist of biocompatible materials (SR 7.1) 
? It has to be of cylindrical shape (SR 9.1) 
? Its maximal length is 14 mm (SR 9.2) 
? Its maximal diameter is 3.6 mm (SR 9.3) 
 
The electrical power (I8) and the generated vibration (I17) have to pass through the 
housing wall without causing leakage (SR 7.2). Thus one face side of the housing cylinder 
is closed with a hermetic feedthrough in order to pass the electrical connection. The other 
face side has to be closed with a compliant element that allows moving the artificial incus. 
 
Generation of vibrations function F1.3: 
Now everything is prepared to search for the key function F1.3 of the acoustic hearing 
implant system S1. Before starting the search it is useful to summarize the determined 
interface characteristics: 
 
I8 A maximal power of 1 mW will be provided to the actuator (SR 1.1). 
I15 The actuator has to provide a maximal equivalent sound pressure of 125 dB 
(SR 2.1). 
I17 The output spectrum of the actuator has to be similar to the normalized transfer 
function of the middle ear (SR 3.1, SR 3.2 and SR 3.3, Fig. 2-32a). Therefore 
the spring constant of the compliant housing face side I17 and the mass of the 
artificial incus F1.5 as well as the mass of the stapes prosthesis E11 have to be 
taken into account for the calculations. 
 
The normalized middle ear transfer function corresponds in first approximation to a 
second-order low-pass filter with a cutoff frequency of about 1 kHz (Fig. 2-26). From a 
mechanical perspective, this corresponds to the oscillation characteristic of a suspended 
mass (Fig. 2-32b), which defines the first three important parameters of the actuator: 
? the mobile mass m, 
? the spring constant k, 
? and the resonance frequency fres which is defined as follows: 
 
 
m
k
fres
π2
1
=  (1) 
 
Since the goal resonance frequency is 1 kHz (SR 3.1), there is one degree of freedom left 
for the mass and the spring constant. To have an idea of the order of magnitude of these 
two parameters, the human middle ear can give a first indication. The mass of the three 
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ossicles of about 65 mg [46] results in a spring constant of approximately 2.5 N/mm using 
(1). 
 
Considering the fact that the actuator deflection should be maximized while minimizing 
the energy consumption, the mobile mass has to be as low as possible. In first 
approximation, the mobile mass consists of the stapes prosthesis and the artificial incus 
(Fig. 2-32c). The mass of an ordinary stapes prosthesis is about 3 mg. The mass of the 
artificial incus can be preliminarily assessed by considering its dimensions (SR 4.1 and 
SR 4.2) and the specific mass of titanium (SR 7.1) of 4.5 g/cm3. This results in an artificial 
incus mass of 4.2 mg. The sum of 7.2 mg is far below the mass of the three ossicles what 
is promising in regard to the actuator efficiency. 
 
The potential of this low mobile mass can only be exploited if the spring constant is much 
lower than that of the middle ear. If not, the mass has to be artificially increased to keep 
the resonance frequency at 1 kHz.  
 
At this stage, the compliant face side of the actuator housing I17 has to be examined in 
more detail. The preferred and simplest solution would be a flat diaphragm. Such a 
diaphragm would act as a spring and, therefore, suit the basic concept of a suspended 
mass if the spring constant of the diaphragm is within an acceptable range. The spring 
constant of a circular diaphragm, kD, with a rigid center (Fig. 2-31) is given by the 
following formula [47]: 
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Where: od 3.6 mm (maximal actuator diameter)  
id 1.0 mm (estimated diameter of the actuator shaft)  
th 25 μm (minimal thickness to allow reliable laser welding)  
ETi 116 GPa (Young’s modulus of titanium)  
νTi 0.34 (Poisson coefficient of titanium) 
 
The spring constant calculated with the above parameters is 6.9 N/mm, which is higher 
than the 2.5 N/mm of the middle ear. This would lead to a shift of the frequency response 
if the small mobile mass of 7.2 mg is taken into account (Fig. 2-32d). 
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Diaphragm  
Fig. 2-31: Geometrical parameters of a diaphragm with rigid center 
 
The following two main approaches are considered to decrease the spring constant: 
? Direct solution: Create a more sophisticated geometry of the compliant 
encapsulation portion with a spring constant lower than that of a simple 
diaphragm (e.g., bellows). 
? Indirect solution: Add an element that compensates for the high diaphragm 
rigidity. 
 
The direct solution is rejected because the feasibility, costs and reliability of a more 
complicated housing structure are questionable (cf. sub-section 2.2.2, M.E.T./Carina). 
The implementation of such a delicate flat diaphragm pushes the available processes 
already to their limits. Hence, the indirect solution seems more interesting. 
 
If an armature is placed in between two magnets and interconnected with the diaphragm, 
the attraction force exerted by the magnets works against the deflection force of the 
diaphragm (Fig. 2-32e). This circumstance can be mathematically represented by 
introducing a spring constant related to the magnets, kM. kM has a negative value because 
the armature is forced to deflect as soon as it leaves the unstable equilibrium in the center 
of the two magnets. The overall actuator spring constant k is thus calculated as follows: 
 
 k = kD + kM (3) 
 
To summarize, by designing from the given interfaces towards the core of the actuator, it 
is possible to define a basic mechanical structure that already incorporates most of the 
required functions. The actuator consists of a hermetically sealed, biocompatible titanium 
housing with a diaphragm serving at the same time as a sealing element and as a 
 
suspension for the mobile structure. The mobile structure comprises an interface for the 
attachment of the stapes prosthesis (an artificial incus) and an armature between two 
magnets to adjust the spring constant of the system. This basic actuator structure is able 
to provide a frequency response similar to the middle ear and, at the same time, it allows 
for minimization of the mobile mass. The only missing element is the excitation 
mechanism that causes oscillation of the armature in response to the delivered sound 
signal. Because the existing part already contains a first magnetic circuit composed of the 
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magnets and the armature, a coil was added to modulate the magnetic flux in order to 
vibrate the armature (Fig. 2-32f). 
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Fig. 2-32: Search for solution process for the generation of vibrations function F1.3: a) 
schematic middle ear with its frequency response, b) corresponding 
mechanical structure: suspended mass, c) the actuator coupling structure, 
artificial incus and stapes prosthesis represent the mass, d) the housing with 
a diaphragm playing the role of the spring is added; due to the high spring 
constant, the transfer function is shifted, e) the added magnets and armature 
compensate for the high diaphragm rigidity and correct the transfer function 
and f) a coil is added to excite the armature 
 
The result is a dedicated implementation of the balanced armature actuator principle. The 
fact that balanced armature actuators are used for highly efficient, miniaturized hearing 
aid loudspeakers confirms that the proposed principle should be well suited for acoustic 
applications. Fig. 2-33 shows a schematic representation of all active actuator elements 
that represent the solution for function F1.3. 
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Magnets
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Soft magnetic sleeve
 
Fig. 2-33:  Schematic representation of the solution for the generation of vibrations 
function F1.3 comprising two ring magnets (the arrows indicate their 
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polarization), a coil (crossed squares), a soft magnetic armature and a soft 
magnetic sleeve. The coil flux (indicated in the lower half of the actuator) 
asymmetrically modulates the flux of the magnets (shown in the upper half) in 
the two air gaps and, therefore, generates an axial force 
 
2.4 Summary and Discussion 
The systematic step-by-step approach and the graphical representation of the whole 
system including its environments and the interactions enable an efficient conceptual 
design process with the following characteristics: 
? The system is directly based on the natural functions of the ear 
? The user and system requirements can be directly derived from the introduced 
environments and the graphical representation helps recognizing which system 
elements are concerned 
? Working with the system diagram helps splitting high level functions into 
manageable sub-functions which is an essential step towards the conceptual 
design 
 
Applying the proposed methodology highlights the important interaction between the 
actuator mechanism and its hermetic encapsulation. Instead of joining two individual 
solutions, in this case an integrated solution is evoked by the methodology. By 
considering the encapsulation as a functional part of the actuator mechanism, both 
contribute to the required actuator characteristic and do not impede each other. This 
seems to be innovative compared to the actuators of the already existing hearing implants 
(sub-section 2.2.2). They all possess a compromise solution between actuator 
mechanism and encapsulation that limits the device performance. The actual 
performance of the actuator is presented in section 4.1. It will be shown that the system 
requirements are met and even exceeded. 
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3 Investigational Device 
3.1 Introduction and Overview 
This chapter presents the investigational DACS device shown in Fig. 3-1. The physical 
device corresponds exactly to the conceptual system diagram shown in Fig. 2-27. The 
external audio processor corresponds to the external part S1.1, the percutaneous 
connector, lead and actuator form the hearing implant S1.2.1 and the fixations system 
represents S1.2.2. 
 
Special attention is paid to the actuator. A summary of the detailed actuator design 
process shows how the conceptual design presented in sub-section 2.3.7 is implemented. 
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Fig. 3-1:  Investigational DACS device that represents the acoustic hearing implant S1 
 
3.2 Actuator 
3.2.1 Detailed Design 
The actuator finally consists of the following three functions that were identified in sub-
section 2.3.7: generation of vibrations F1.3, hermetic housing F1.4 and artificial incus 
F1.5. All three have direct impact on the actuator functional characteristic as shown in 
Fig. 3-2. The functional parameters that describe the actuator performance characteristic 
are: 
R electrical resistance of the coil 
L actuator coil inductance 
β electro-mechanic conversion constant 
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m mobile actuator mass including the armature, the actuator shaft, the 
artificial incus and the stapes prosthesis (the mass of the diaphragm 
is sufficiently small to be neglected) 
kD diaphragm spring constant 
kM negative spring constant representing the attraction force of the 
magnets 
c actuator damping coefficient 
cL mechanical impedance of the cochlea (represents the actuator load) 
 
Coil: R, L
Diaphragm: kD
Generation of vibrations F1.3 Diaphragm I17
Artificial
incus F1.5
Mobile mass: m
Attraction force of magnets: kM
Electro-mechanic
conversion constant: β
Damping
coefficient: c
Stapes
prosthesis E10 Cochlea E2
Mechanical impedance
of the cochlea: cL
Hermetic housing F1.4
Feed-
through I8
 
Fig. 3-2:  Actuator functions, corresponding concepts, relevant environments and 
resulting functional parameters 
 
The diaphragm I17 plays a key role regarding the integration of the different actuator 
functions. It is at the same time part of the hermetic housing F1.4, defines the frequency 
response of the generation of vibration function F1.3 and provides radial guidance of the 
actuator shaft. 
 
The next step is to set up models that link the identified functional parameters to the 
performance characteristics of the actuator. These models have to be as simple as 
possible and as accurate as necessary in order to minimize development efforts. 
Therefore it is decided to work with the following two main models: 
? A lumped parameter model directly derived from the basic actuator structure in 
Fig. 3-2 which simulates the frequency response of the actuator 
? A static finite element model to simulate the magnetic circuits and to calculate 
the electro-mechanic conversion constant β as well as the attraction force of the 
magnets, represented by kM 
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Lumped Parameter Model of the Actuator Dynamics 
Fig. 3-3 presents the selected lumped parameter model. It consists of the electrical and 
the mechanical parts of the actuator, coupled together by electro-mechanic conversion 
constant β. 
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Fig. 3-3:  Network of the lumped parameter model of the actuator and its load 
 
Where: ue actuator excitation voltage    [V] 
u coupling voltage     [V] 
I current of the actuator coil    [A] 
v velocity of the armature    [m/s] 
F magnetic force exerted on the armature [N] 
 
An inverse analogy (Table 3-1) is chosen for the electro-mechanical coupling that links 
the electrical current to the mechanical force [48]. This is the common approach for 
electro-mechanic actuators, since the generated force is proportional to the current as 
described by the following formula: 
 F = β i (4) 
Consequently, the velocity is linked to the voltage by the following formula: 
 β
u
v =  (5) 
Table 3-1: Analogies between electrical and mechanical parameters of the lumped 
parameter model  
Electrical Parameters Mechanical Parameters Analogies 
Resistance R [Ω] Damping c [kg/s] R = β2 / c 
Inductance L [H] Compliance 1 / k [m/N] L = β2 / k 
Capacitance C [F] Mass m [kg] C = m / β2 
Impedance Z [Ω] Admittance Ym [1/Ωm] Z = β2 / Ym 
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It is assumed that the actuator behaves linearly up to 1 mW power supply. Thus, all 
model parameters are considered to be constant within the specified working range. 
Published measurements have shown that the actuator load cL can be represented by a 
pure damping element of 21.1·109 kg/s·m4 [49]. This acoustic impedance is coupled to the 
actuator through the stapes prosthesis. Therefore it has to be multiplied with the square of 
the prosthesis cross section of 0.28 mm2 to calculate the equivalent mechanical damping. 
The transformed cL value of 0.0017 kg/s is negligible in comparison with the default 
actuator damping coefficient c of 0.01 kg/s (see below) and therefore not considered in 
the model calculations. The actual influence of the load is discussed in more detail in 
section 5.4. 
 
The velocity, which indicates the actuator performance, is calculated as follows: 
 
  
ββ
m
e
Y
Z
u
v
+
=  (6) 
 
Where: Z = R + jωL:  electric actuator impedance   [Ω] 
Ym = jωm + c + k/jω: mechanic actuator admittance  [1/Ωm] 
 
Finite Element Model of the Actuator 
The static finite element model is used to assess the influence of the detailed actuator 
geometry on the model parameters β and kM. The magnets are represented by a two  
 
Cu Sm2Co17NiFe
 
Fig. 3-4:  Meshed axi-symmetric finite element actuator model comprising magnets, 
armature, armature shaft, coil and sleeve 
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parameter model considering remanence and coercivity. The model of the soft magnetic 
NiFe alloy takes into account saturation induction and maximal permeability of the 
material. The copper coil was modeled by a current density region. The axial symmetry of 
the actuator allowed for a simple two-dimensional model (Fig. 3-4). 
 
A two-step parametrical study is done in order to determine the values of the 20 
geometric parameters (Fig. 3-5). First, the magnet flux circuit is designed to adjust kM to 
kD. Second, the remaining geometric actuator parameters are adjusted in order to 
maximize β. 
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Fig. 3-5:  Geometric parameters of the finite element model 
 
The design of the magnet flux circuit (Fig. 3-6) starts with a first rough assessment of the 
mobile actuator mass m taking into account the actuator dimensions. This results in a 
target value for kM by applying (1) and (3). Then the geometry of the magnets, the 
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surrounding nickel iron structure and the armature are manually adjusted in order to reach 
the target value of kM while respecting the following design rules: 
? The distance between armature and the magnets has to be at least 0.1 mm in 
order to respect part and assembly tolerances 
? The thickness of the magnets has to be at least 0.3 mm in order to respect 
fabrication limits 
? The flux density of the surrounding soft magnetic structure has to stay below 
the saturation value of the material (Fig. 3-7) 
? The value of kM has to stay constant within the deflection range of the actuator 
of +/- 0.015 mm (Fig. 3-8) 
 
 
Fig. 3-6: Magnet flux lines (no coil current) 
 
 
Fig. 3-7:  Magnet flux density plot of the longitudinal actuator section (no coil current) 
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Fig. 3-8:  The slope of the force curve that corresponds to kM is very constant within 
the intended actuator deflection range of ± 0.015 mm (shaded range) 
 
kM is assessed by translating the armature and its shaft in the axial direction and 
calculating the force between the mobile and the static part of the actuator. Eventually the 
dynamic actuator characteristics are fine-tuned by adjusting the thickness of the armature 
(AL) in order to achieve a resonance frequency of about 1 kHz according to (1). The 
resulting lumped model parameters values are: 
? m = 35 mg 
? kM = -5.9 N/mm 
 
The determination of the remaining geometric parameters specifying the coil and the soft 
magnetic structure (Fig. 3-9) is done manually as well. The main goal is to maximize β 
and therefore the efficiency of the actuator. The additional design rules and guidelines, 
that have to be respected, are: 
? The reluctance of the radial air gap between armature shaft and the actuator 
sleeve has to be minimized while keeping a minimal distance of 0.1 mm in order 
to consider reasonable part and assembly tolerances 
? The flux density of all soft magnetic parts has to stay below saturation when a 
current equivalent to 1 mW input power is applied 
? The maximal length of the actuation mechanism has to stay below 8 mm. (The 
remaining 6 mm of the total actuator length of 14 mm were used for the 
feedthrough and the connection of the lead.) 
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Fig. 3-9: Coil flux lines (the magnets are removed from the model to make the much 
weaker coil field appear) 
 
Fig. 3-10 shows exemplarily the influence of the geometric parameter ASR on β. The 
armature shaft radius (ASR) was varied between 0.1 mm and 0.35 mm (Fig. 3-5). The 
result shows that the radius must be maximized in order to maximize β. Therefore the 
preferred value corresponds to the upper limit of the admissible parameter rage. In this 
case the maximal radius is 0.3 mm in order to keep a minimal radial air gap of 0.1 mm 
(first design rule of the above list). 
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Fig. 3-10:  Influence of the geometric parameter ASR (Fig. 3-5) on β 
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β was assessed by calculating the force between the mobile and the static part of the 
actuator in function of the applied current. The resulting value of β is: 
? β = 2.25 N/A 
 
Remaining Lumped Model Parameters and Simulated Actuator Performance  
An initial actuator-damping coefficient c is determined based on preliminary diaphragm 
characterization. The spring constant and the damping coefficient are assessed by 
measuring the frequency response when a known mass is attached in the center of the 
diaphragm. Thereto the diaphragm is clamped on its circumference and mounted on a 
shaker. The frequency response is measured using laser Doppler vibrometry (PSV 200, 
Polytec GmbH, Waldbronn, Germany). Then the damping coefficient is determined by 
fitting the height of the resonance peak with measurements of the frequency response 
and the final value is obtained: 
? c = 0.01 kg/s 
 
Resistance R and inductance L of the actuator are not limited by the actuator design 
itself. In fact, the electronic driver of the actuator imposes their values, which can be 
adjusted by varying the coil wire diameter (only for R) and the number of turns. In order to 
reach 1 mW of power consumption when the maximal driver voltage is applied, their 
values are set to: 
? R = 12 Ω (the difference to the specified value of 44 Ω (SR 1.2) is due to the 
resistance of the lead of 32 Ω that has to be subtracted from the required value 
in order to determine the coil resistance R) 
? L = 7.5 mH 
 
Having defined all parameters of the lumped parameter model, it is possible to verify if the 
actuator theoretically meets the main requirement, namely, if it achieves an equivalent of 
125 dB SPL with 1 mW of input power. For that purpose it is necessary to convert sound 
pressure into velocity of a stapes prosthesis vibrating in the cochlea. The basis of this 
conversion is the normalized middle ear transfer function specified in ASTM-2504 (Fig. 
2-26). It defines the stapes velocity corresponding to a sound pressure of 1 Pa (94 dB 
SPL) in front of the tympanic membrane at discrete frequencies from 125 Hz to 6’000 Hz. 
Because, in this case, the stapes is replaced by a prosthesis, it is important to take the 
reduced active section into account. Considering a midsized stapes prosthesis with a 
diameter of 0.6 mm and an average stapes footplate area of 3.2 mm2, the required 
velocity is eleven times higher than the velocity of the normal stapes. Fig. 3-11 shows the 
promising result. Based on these simulations, the actuator should be able to meet the 
required performance. 
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Fig. 3-11:  Simulated actuator performance in comparison with the required velocity to 
reach an equivalent of 125 dB SPL 
 
3.2.2 Physical Implementation 
Fig. 3-12 shows a cross section through the final actuator and indicates its main 
components. Its housing is a titanium cylinder with a laser welded glass feedthrough on 
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Fig. 3-12:  Longitudinal section through the DACS actuator 
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the backside. It provides the terminals for the connection of the lead. The connection site 
is protected by a silicone filled cap. On the front side, the housing is closed with a laser 
welded titanium diaphragm. The armature assembly is attached to the center of the 
diaphragm after a special centering procedure. The external titanium part is composed of 
a thin shaft with a silicone coated artificial incus attached to its tip (Fig. 3-13). This 
guarantees that only implantable-grade materials are in contact with human tissue. 
Functional but toxic materials like rare earth magnets, soft magnetic alloys and the copper 
coil are all sealed within the hermetic encapsulation. 
 
 
Fig. 3-13:  Photo of the DACS actuator 
 
3.3 Percutaneous Connector and Lead 
The percutaneous connector system (Cochlear Ltd., Sidney, Australia) enables direct 
electrical connection of the actuator to the output stage of the external hearing system. 
The future product will provide transcutaneous signal and power transmission (sub-
section 6.3.2) that will have reduced efficiency and reduced bandwidth compared to the 
direct percutaneous transmission. The specified actuator efficiency of 125 dB SPL with 
1 mW input power takes the reduced efficiency of a transcutaneous transmission into 
account. 
 
The lead interconnecting the actuator to the percutaneous pedestal is based on a 
cochlear implant electrode lead (Cochlea Ltd., Sidney, Australia). It consists of two times 
eleven thin platinum wires that are coiled and encapsulated in a silicone tube (Fig. 3-14). 
This guaranties the required flexibility of the lead in order to resist against the fatigue. 
 
Coiled platinum wires
 
Fig. 3-14:  Close-up of the actuator lead 
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3.4 External Audio Processor 
The externally worn audio processor (Fig. 3-15) is based on the digital multi-channel 
hearing aid systems Aero 211 and Savia 211 respectively (Phonak AG, Stäfa, 
Switzerland). It contains two microphones, a digital signal processing unit and a battery. 
The signal-processing unit features multichannel compression, noise and feedback 
canceling as well as a multi-microphone noise reduction system. The provided frequency 
range of 125 Hz to 8’000 Hz is smaller than the one of the actuator and, therefore, defines 
the system limit. 
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Fig. 3-15:  External audio processor 
 
The loudspeaker of the hearing aid is removed and replaced with a connector. Connector 
and hearing aid are encapsulated within a second housing that allowed to attach the 
audio processor directed on the percutaneous pedestal of the implant. This provides the 
advantage that the external device components can be hidden under the hair (Fig. 3-16). 
 
 
Fig. 3-16:  Left: percutaneous pedestal, right: external audio processor that is put on the 
pedestal 
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3.5 Fixation System 
The fixation system (Fig. 3-17) that anchors the actuator to the cranial bone of the patient 
is based on a small titanium bone plate used in craniomaxillofacial trauma surgery. This 
part of the fixation system can be intra-operatively bent by the surgeon to fit the curvature 
of the skull and to bring the actuator axis into the correct position. Conventional titanium 
bone screws are used to attach it. The plate is augmented with a special clamping 
mechanism that receives the actuator. The clamping mechanism provides two degrees of 
freedom for precise positioning of the actuator. The actuator can be freely translated in 
the direction of its axis and be rotated around its axis. The clamp is closed using a 
screwdriver with torque limitation. This guarantees that the actuator is clamped within the 
intended force range. Once the device is well placed, the clamping mechanism is locked 
with a catch to secure the attachment of the actuator. 
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Fig. 3-17:  Fixation system with screwdriver and safety catch 
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4 Device Verification 
4.1 Introduction 
As described in sub-section 1.6.2, the verification of the system characteristics consists in 
verifying all system requirements SR 1.1 to SR 12.2. This can be a simple measurement 
of a dimension such as the actuator diameter (SR 9.3), or a quite complex measurement 
of the actuator frequency response in order to verify SR 3.1, SR 3.2 and SR 3.3. 
 
This chapter will not cover all performed verification tests, but will concentrate on the 
functional tests that are directly related to the actuator performances, reliability and 
robustness. These are the key characteristics that will show if the actuator is qualified for 
implantation. 
 
4.2 Actuator Performances 
The verification of the actuator performances includes several aspects that are all verified 
by assessing the actuator frequency response. The actuator frequency response shows if 
the frequency characteristic is similar to the one of the human middle ear (SR 3.1, SR 3.2 
and SR 3.3), if the actuator efficiency is sufficient to reach an equivalent output of 125 dB 
SPL with 1 mW power input (SR 1.1 and SR 2.1) and if the frequency range is 100 Hz to 
10’000 Hz (SR 2.2). 
 
Fig. 4-1 shows the measurement set-up that is used to assess the actuator transfer 
function. The measurement system is based on a Laser Doppler Vibrometer (PSV 200, 
Polytec GmbH, Waldbronn, Germany). With its internal signal generator it excites the 
actuator within the frequency range of 100 Hz to 10’000 Hz and measures in response 
the actuator driving voltage as well as the velocity of the artificial incus. The transfer 
function is finally calculated by dividing the velocity through the driving voltage. 
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Fig. 4-1: Actuator transfer function measurement set-up 
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Based on the actuator transfer function and the electrical actuator parameters it is then 
possible to calculate the actuator output velocity for a power input of 1 mW. Thereto the 
actuator driving voltage U1mW that corresponds to a power consumption P of 1 mW needs 
to be calculated by the following formulas: 
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The artificial incus velocity is finally obtained by multiplying the measured transfer function 
with U1mW. Fig. 4-2 shows the corresponding result in comparison with the required 
velocity to reach an equivalent of 125 dB SPL and the lumped element model calculation. 
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Fig. 4-2:  Measured actuator performance in comparison with simulation results and 
the requirement (the actuator damping coefficient c was adjusted to 0.06 
kg/s) 
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Four conclusions are drawn from Fig. 4-2: 
 
First, the measurement shows a sharp parasitic resonance just below 2 kHz. This 
resonance is due to the fact that the mass of the artificial incus is not centered on the 
actuator shaft. This causes a lateral vibration mode of the coupling structure at the 
observed frequency. Once the actuator is implanted and coupled via a stapes prosthesis 
to the inner ear, this lateral mode is strongly attenuated (section 5.4). 
 
Second, after fitting of the actuator-damping coefficient, the measured and simulated 
curves are almost congruent. This proves that the lumped element model describes the 
actuator accurately and is, therefore, a suitable design tool. 
 
Third, because the provided velocity of the actuator driven with 1 mW input power 
exceeds the required 125 dB curve in the whole frequency range from 100 Hz to 
10’000 Hz by an average of 5 dB, the actuator is even more efficient than required. This 
performance reserve allows for the acceptance of actuators with less ideal frequency 
responses and resonance frequencies of up to 2 kHz to increase the device-
manufacturing yield. 
 
Fourth, the actuator characteristic follows the middle ear characteristic very precisely. 
This means that this major design goal is achieved. Only at the resonance is the actuator 
less damped than a normal human middle ear and shows a deviation of the curve 
progression. This under-damping is important in accounting for the additional damping 
due to the coupling and particularly tissue growth as shown in section 5.4. 
 
Finally it can be concluded, that the actuator meets all the specified performance 
requirements. 
 
4.3 Actuator Reliability 
The verification of the reliability has to prove that the actuator will operate for the specified 
lifetime of two years (SR 6.1) without losing its hermeticity (SR 7.2). This is essential for 
the therapeutic performance of the device. If the actuator would become leaky, the patient 
would be at risk and the device would have to be explanted. 
 
The big challenge in this case is to accelerate the corresponding tests in order to verify 
the device lifetime within a reasonable period of time. In most of the cases the necessary 
acceleration is accomplished by increasing the temperature and by exceeding the 
specified power limit of the device. Unfortunately, this procedure requires that the impact 
of these factors is exactly known. Since the present device is the first of its kind, this 
required knowledge is not yet available. Therefore another approach has to be found. 
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The selected approach is based on two tests. First of all, the actuator is analyzed in order 
to identify its weakest element. Regarding the actuator design (Fig. 3-12) it is apparent 
that it is the diaphragm. This titanium foil with a thickness of 25 µ m is constantly under 
mechanical stress and has at the same time to maintain the hermeticity of the actuator. 
Therefore a diaphragm fatigue test is carried out in order to assess its fatigue limit (sub-
section 4.3.1). 
 
The second test is a life cycle test of the complete actuator (sub-section 4.3.2). The 
reason for this test is to monitor the long term behavior of a complete actuator. 
 
4.3.1 Diaphragm Fatigue 
Titanium shows a particular fatigue behavior that differs from other nonferrous metals. 
Instead of a stress vs. load cycles characteristic that slopes gradually downwards with 
increasing number of cycles, titanium shows a limit stress value (fatigue limit). If the 
stresses stay below this limit, the mechanical structure can endure an infinite number of 
cycles without failure (Fig. 4-3). Literature shows that this limit is reached between 105 
and 107 cycles. To be on the save side, the tests described below will be carried out with 
107 cycles. 
 
 
Fig. 4-3: Typical stress vs. cycles characteristic of titanium [50] 
 
A strain-controlled fatigue test is carried out. The corresponding staircase test procedure 
is described in [51]. The test set-up is shown in Fig. 4-4. It is based on load generator 
developed for this specific purpose. 
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Fig. 4-4: Diaphragm fatigue test set-up: the load generator deflects the diaphragm of 
the clamped test housing; the deflection amplitude is monitored by the laser 
vibrometer 
 
The assessed fatigue limit of the diaphragm is 2.5 times above the maximal specified 
actuator velocity considering a failure probability of 10-4, a confidence of the assessed 
mean value of 99% and a confidence of the assessed standard deviation of 90%. This 
shows that the maximal strain of the diaphragm that occurs during intended operation of 
the device stays below the fatigue limit. The diaphragm should therefore stay intact during 
the specified lifetime of two years with a probability of more than 99.99%. 
 
4.3.2 Life Cycle Test 
As mentioned above, it does not make sense to accelerate the aging of the actuator. 
Therefore it is decided to run test actuators at worst but still representative conditions 
(Fig. 4-5): 
? Input power: 1 mW 
? Temperature: 37°C 
? Humidity: 100% 
? Load:  artificial cochlea 
? Device activation: continuous 
 
The test is started three months prior to first human implantation. In this way the aging of 
the test actuators is at least three months in advance compared to the implanted devices 
in order to provide enough reaction time in case of a test device failure. The test actuators 
are inspected in regular intervals. These inspections include the verification of the main 
actuator characteristics like frequency response and encapsulation integrity. 
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Fig. 4-5: Life cycle test set-up: the actuators are placed in a climatic chamber that 
simulates implanted conditions (37°C and 100% humidity); the actuators are 
driven with the specified maximal power input of 1 mW and coupled to an 
artificial cochlea 
 
Up to date the test is continuously running for six years without causing any actuator 
failure. This confirms the result of the diaphragm fatigue test and proves that the actuator 
lifetime exceeds the required two years. 
 
4.4 Actuator Robustness 
Two main aspects regarding the device robustness are: 
? The device has to withstand all the necessary manipulations related to the 
implantation procedure 
? The device has to withstand environmental conditions during transportation, 
storage and intended use 
 
4.4.1 External Forces 
The attachment of the stapes prosthesis to the artificial incus is the most critical 
implantation step from the actuator perspective. This manipulation exerts forces on the 
mobile part of the actuator and therefore deflects the diaphragm. This involves the risk of 
damaging the diaphragm and causing a leak or a change of the actuator frequency 
response. Therefore the actuator has to withstand forces that are exerted during this 
implantation step (SR 10.1 and SR 10.2). 
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The test procedure consists of the following main steps: 
? Measurement of the actuator frequency response prior to application of the load 
forces 
? Application of multiple force cycles on the artificial incus in axial and radial 
direction 
? Measurement of the actuator frequency response after the application of the 
load forces 
 
The comparison of the two assessed frequency responses does not show a significant 
change of the actuator characteristic. This proves that the actuator is not affected by the 
necessary manipulations during implantation. 
 
4.4.2 Environmental Influences 
An active implantable medical device has to be 100% functional at the moment of 
implantation. Implanting a defective device would have fatal consequences and has to be 
prevented. Therefore all active implantable medical devices have to be sufficiently robust 
to withstand any environmental influence during transportation, storage and intended use. 
The corresponding requirements are specified in EN45502 and include pressure (SR 11.1 
and SR 11.2), mechanical shock (SR 5.1) and temperature (SR 11.3 and SR 11.4) 
resistance. 
 
The actuator is very sensitive to pressure and temperature because of its hermetic 
housing design. The diaphragm becomes deflected in response to pressure and 
temperature changes and could therefore be damaged. Mechanical shocks are less 
critical because the mobile actuator mass of 35 mg is sufficiently small that shocks cannot 
cause significant forces. 
 
All three environmental influences are tested according to the same basic procedure, 
which is already described in the previous sub-section: 
? Measurement of the actuator frequency response prior exposure to the 
corresponding environmental influence 
? Exposure of the actuator to multiple environmental load cycles 
? Measurement of the actuator frequency response after exposure 
 
None of the three tested environmental influences caused a significant change of the 
actuator frequency response. This proves that the actuator does withstand the stresses 
that can occur during transportation, storage and intended use of the device. 
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4.5 Conclusion 
The verification of the actuator characteristics against the specified system requirements 
was successful. This means that the actuator meets all system requirements and is 
therefore qualified for implantation. It has to be kept in mind that this “only” signifies that 
the actuator is as good as its requirements. It does not automatically guarantee that the 
actuator provides a sufficient therapeutic performance. Nevertheless the design aimed to 
cover all important aspects with help of the presented conceptual design methodology. 
This should ensure that the technical performance is representative for the final 
therapeutic performance. The corresponding validation step is described in the next 
chapter. 
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5 Therapy Validation 
5.1 Introduction 
Is the described and applied methodology able to provide a conceptual design that leads 
to a “useful” device? This question shall be answered in this chapter that summarizes the 
clinical study which started about twelve months after the project initiation. If its results 
confirm a satisfying therapeutic performance of the device, this will prove that conceptual 
design is well adapted to the present application and that all relevant environmental 
influences were properly considered. 
 
5.2 Summary of Clinical Study Protocol 
A well specified clinical protocol is essential for the validation of a new therapy. The study 
goals, the corresponding test procedures and the included patient population have to be 
carefully chosen in order to get meaningful results. Ethical aspects have to be considered 
as well. The risk for the patient has to be minimized and has to be in a justifiable 
proportion to the possible benefit.  
 
The study goals were defined as follows: 
 
Primary objective: To demonstrate that the DACS system can efficiently manage 
severe to profound mixed hearing loss 
 
Secondary objectives: 1) To demonstrate safety and feasibility of the surgical procedure 
for the DACS actuator combined with a stapes prosthesis 
  2) To demonstrate safety of using the DACS actuator combined 
with a stapes prosthesis 
 
The primary study objective is verified by assessing the post-operative aided free field 
hearing thresholds of the patients. The thresholds have to be better than 40 dB HL at 500, 
1000, 2000 and 4000 Hz. 
 
The secondary study objectives were verified by reporting and analyzing 
? all surgical complication related to the implantation of the device 
? the aided hearing performance during the length of the study including 
improvement or degradation of the device performance 
? all post-operative complications related to the device 
 
The patients included in the study had to fulfil the following criteria: 
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? Bilateral or unilateral mixed hearing loss with a conductive component due to 
otosclerosis and a sensorineural component (since a patient with otosclerosis 
would be indicated for stapedectomy in any case, the implantation of the DACS 
device did not much increase the patient risk) 
? Measurable bone conduction thresholds at 500, 1000, 2000, 3000 and 4000 Hz 
with standard clinical equipment (this ensured that the sensorineural loss was 
not to severe for post-operative DACS usage) 
? Sensorineural loss less than that indicated for a cochlear implant 
? Bone conduction thresholds greater than 40 dB for at last three out of the five 
frequencies mentioned above and bone conduction thresholds equal or greater 
than 30 dB on all frequencies (this ensured that even though normal 
stapedectomy will be successful, the patient still needed a hearing aid post 
surgery) 
? Air-bone-gap equal or greater than 20 dB for at least three out of the five 
frequencies mentioned above (this ensured that the patients were candidates 
for stapedectomy) 
? Audiometric follow-up data available from at least one year before enrolment 
(this was important to have a reliable assessment of the patient’s hearing loss) 
? Progression of the sensorineural component of the hearing loss less than 10 dB 
measured over the last year (this ensured that the DACS device was able to 
restore the hearing loss until the end of the clinical study after two years) 
? Experience with conventional high power hearing aids for a minimum of six 
weeks prior to enrolment (since the operation of the DACS device is identical to 
that of a conventional hearing aid, this ensured that the patients were able to 
correctly operate such a device) 
? Willingness to participate in the study and sign the informed consent (the 
patients had to be conscious of the risks of the clinical study in order to kept 
their expectations at a realistic level) 
 
Excluded from the study were patients that fulfilled the following criteria: 
? Inability to comply with the study follow-up 
? Failure to obtain written informed consent 
? Medical contra-indication that would prevent surgery 
? Unrealistic expectations regarding the outcome of the intervention 
? Anyone under the age of 18 
? Inability to maintain personal hygiene in order to keep the percutaneous 
pedestal clean 
 
An additional goal of this clinical study was to compare the therapeutic performance of the 
DACS device with the current reference treatment consisting of the combination of 
stapedectomy and a conventional hearing aid (sub-section 1.5.1). This was possible due 
to a special surgical technique described in detail in section 5.4. In order to minimize the 
consequences for the patient in case of a DACS device failure, a conventional 
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stapedectomy was added to the implantation of the DACS device (Fig. 5-2). This allowed 
to directly compare the two therapies. 
 
5.3 Summary of Clinical Study Results 
Fig. 5-1 summarizes the main therapeutic outcome of the clinical study. The very high 
pre-operative air conduction thresholds of the four patients caused a pre-operative 
speech discrimination of 0% (Table 5-1). The DACS device reduces the thresholds 
considerably and brings them to 40 dB HL or lower on almost all measurement points. 
This means that the primary objective of the clinical study is achieved. The corresponding 
increase in speech discrimination is considerable and reaches even 100% in some cases. 
This confirms the therapeutic benefit of the DACS device. 
 
Table 5-1: Improvement of the speech discrimination of the four DACS patients, data 
from [52] 
Speech Discrimination Scores  
60 dB 75 dB 90 dB 
Pre-operative 0% 0% 0% 
Patient 1 
With DACS 25% 65% 70% 
Pre-operative 0% 0% 0% 
Patient 2 
With DACS 80% 100% 90% 
Pre-operative 0% 0% 0% 
Patient 3 
With DACS 70% 100% 90% 
Pre-operative 0% 0% 0% 
Patient 4 
With DACS 10% 40% 25% 
 
If the aided thresholds with the DACS device are compared with stapedectomy and 
conventional hearing aid (Fig. 5-1), it can be further concluded that the DACS device 
provides better results. There is a clear improvement of the thresholds at low and high 
frequencies. This means that the DACS device performs better than the current reference 
therapy which should justify the related disadvantages like higher device costs and more 
invasive surgery. 
 
The four implantations have demonstrated that the surgical procedure for the DACS 
actuator combined with a stapes prosthesis is safe. No adverse event was reported for 
any of the four implantations. Further, no post-operative complications were reported 
regarding the actuator combined with a stapes prosthesis. This shows that the secondary 
study objective was achieved as well. 
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Since all study objectives were successfully achieved, it can be concluded that device 
concept is appropriate. This implies that the applied conceptual design methodology has 
provided useful output. 
 
Patient 1
 
 
Patient 2
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Patient 3
 
 
Patient 4
 
Fig. 5-1: Hearing thresholds of the four DACS patients indicating their pre-operative 
air conduction thresholds (circles and crosses) and the post-operative aided 
thresholds (squares and triangles); DACS: continuous lines, stapedectomy 
and conventional hearing aid: dashed lines, data from [52] 
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5.4 Surgical Procedure 
Fig. 5-2 shows the situation after implantation of the investigational DACS device. The 
actuator is placed in a temporal bone cavity that was drilled by surgeon (Fig. 5-3b). It is 
hold in place by the fixation system which is screwed to the cranial bone (Fig. 5-3c). The 
percutaneous pedestal is screwed a little bit more behind. As shown in the magnified view 
through the auditoy canal, two stapes prostheses were implanted. One is attached to the 
artificial incus of the actuator (Fig. 5-3f) and a second one is attached to the real incus like 
during a conventional stapedectomy (Fig. 5-3d). 
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Fig. 5-2: Schematic drawing of the implanted investigational DACS device, modified 
after [52] 
 
In the case of the DACS device, the surgical procedure is more than manipulation of 
human tissue and the placement of device components. The procedure (Fig. 5-3) has 
direct impact on the performance of the device. On the one hand the actuator has to be 
carefully handled in order to prevent damage. On the other hand the attachment and 
placement of the stapes prosthesis directly influence the device performance.  The design 
of the actuator has to account for these influences and to support the manipulation by the 
surgeon as much as possible. These aspects were covered by determining the 
corresponding system environments as prescribed by the conceptual design 
methodology. After placement of all system components, an intra-operative device test 
(section 5.5) was carried out to check the integrity of the system and to verify that the 
stapes prosthesis can freely move within the oval window.  
 
  85 
  
  
  
  
Fig. 5-3: Photos of the main DACS implantation steps: a) incision, b) drilling of the 
bone cavity that receives the actuator, c) placement of the fixation system, d) 
placement of the conventional stapes prosthesis, e) placement of the 
actuator and f) placement of the DACS stapes prosthesis 
 
No one of the four implanted devices was damaged during the placement. Therefore the 
current device seems robust enough to withstand the necessary surgical manipulations 
and can be placed to achieve good therapeutic performance. Nevertheless there was one 
actuator damaged by unpacking the device and several implantation steps could be 
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facilitated by design changes. The following device improvements are proposed to further 
minimize the risk of adverse events during implantation: 
? In order to help the clinic staff to unpack the actuator and the surgeon to 
position it more easily, it is proposed to implement a disposable applicator. This 
applicator is like a little handle that allows to grab and to manipulate the 
actuator without the risk of unintended contact (Fig. 5-4). Once the actuator is 
placed and fixed in the correct position, the applicator is simply pulled off and 
thrown away. 
 
 
Fig. 5-4: Actuator with applicator 
 
? Another detail that could be improved concerns the diaphragm. When the 
actuator is inserted into the clamp of the fixation system, the diaphragm weld 
could be damaged. A little ring that surrounds the diaphragm would provide 
effective protection (Fig. 5-5). 
 
Diaphragm
Protection ring
Silicone filling
Diaphragm weld  
Fig. 5-5: Diaphragm protection ring 
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? The current fixation system does not provide sufficient degrees of freedom to 
fine tune the actuator position as explained in sub-section 6.1.4. An additional 
ball joint (Fig. 5-6) would allow the surgeon to precisely change and adjust the 
orientation of the actuator without spatial limitations. 
 
Bone plate
Ball joint
Actuator clamp
 
Fig. 5-6:  Fixation system with ball joint 
 
? A last improvement would be the change of the artificial incus shape. During the 
clinical trial it appeared that the oval section of the artificial incus limits the 
degrees of freedom of the attached stapes prosthesis. Future actuators should 
provide a circular shaped artificial incus (Fig. 5-7). 
 
Artificial incusCurrent oval section Future circular section
 
Fig. 5-7: Current artificial incus with oval section (left) and future design with 
circular section (right) 
 
5.5 Intra-operative Measurements 
Intra-operative measurements were done for two purposes: as described in the previous 
section, they were necessary to verify the device integrity before stitching up the patient. 
Further they helped confirm the measurements that were done on temporal bone 
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preparations. Of particularly interest were the measurements done prior to explantation of 
the device scheduled after the study period of two years (only one patient agreed to 
explant the device, the other ones insisted in keeping the device due to its satisfying 
performance). This allowed for verification of the long-term stability of the device 
characteristics and for investigation of the influence of tissue growth around the implant. 
Fig. 5-8 summarizes these intra-operative measurements done before explantation. 
 
The measurements confirm that coupling to the cochlear fluid represents a pure damping 
as assumed in sub-section 3.2.1. The initial damping secondary to the coupling eliminates 
the parasitic resonance of the lateral vibration mode that is due to the off-axis position of 
the artificial incus. Once the healing process is complete and tissue has grown around the 
stapes prosthesis, a damping of about 10 dB of the resonance peak can be observed. 
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Fig. 5-8:  Characteristic of an implanted actuator 
 
The intra-operative measurement test set-up is shown in Fig. 5-9. It was based on a laser 
vibrometer like the actuator characterization tests that are done in the laboratory, but 
provided some particularities. One particularity concerns the excitation of the actuator. It 
was not allowed to simply connect the signal generator output to the implanted 
percutaneous pedestal without precautions. First, the patient had to be electrically 
decoupled from the measurement device. This was done by an insulation amplifier which 
only provided battery power to the implant. Further it had to be assured that acoustical 
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stimulation did not exceed harming loudness levels. Another particularity concerned the 
deviation of the laser beam on the artificial incus of the implanted actuator. To access the 
artificial incus in the middle ear cavity a special version of a laser vibrometer (HLV 1000, 
Polytec GmbH, Waldbronn, Germany), which was coupled into the optical path of a 
surgical microscope, was used. 
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Fig. 5-9: Schematic set-up of the intra-operative device integrity test 
 
5.6 Conclusion 
The validation of the DACS therapy against the specified user requirements was 
successful. The clinical study results are very promising and show that the DACS device 
could efficiently treat severe to profound hearing loss in four patients. This confirms that 
the device design is appropriate and that the device verification was representative for the 
final therapeutic performance. 
 
Even if the DACS device could be implanted without important difficulties, some possible 
device improvements were identified during the four implantations. They would further 
improve the usability and reliability of the device. 
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6 Conclusions 
6.1 Overview 
6.1.1 Design Methodology 
This thesis proposes a conceptual design methodology for acoustic hearing implants. The 
methodology was applied to develop an investigational hearing implant that was 
successfully tested and implanted in four patients. Based on this project outcome and the 
experience gathered during the development, it is possible to draw the following 
conclusions regarding the entire design process and the conceptual design methodology: 
? The employed design processes allowed for a fast and efficient development of 
the investigational DACS device. 
? The good clinical study results show that the employed design processes were 
effective. 
? The conceptual design methodology allowed to well analyze the device 
application and to identify the interactions with the involved environments. This 
led to a comprehensive set of user and system requirements. The fact that no 
device failure occurred so far and that the therapeutic performance is satisfying 
indicates that all relevant aspects were considered. 
? The conceptual design methodology helped to well structure the complex 
design task and to break the system down into manageable portions without 
neglecting important design aspects. 
? The conceptual design methodology helped to find an integrated solution by 
considering the interactions between the “generation of vibrations” and the 
“hermetic housing” functions. This was probably the key element that allowed to 
develop a device that seems to outperform comparable devices. 
? The conceptual design methodology led to an innovative actuator concept that 
differs from all hearing implant actuator designs published so far. 
? Since the conceptual design methodology provided a solid system concept, the 
detailed design can be based on simple and efficient procedures. 
? The models used for the detailed design of the actuator represented a good 
compromise between accuracy and simplicity. This was confirmed by the 
simulations results that corresponded well to measured characteristics of the 
actuator. 
 
6.1.2 Therapy 
The results of the clinical study have shown that the DACS device could effectively treat 
severe to profound mixed hearing loss in all four cases. When comparing the DACS 
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therapy with a combination of conventional hearing aid and stapedectomy, which serves 
as reference, it can be observed that  
? The DACS device provides better hearing thresholds at low and high 
frequencies 
? At middle frequencies the DACS device provides at least as good hearing 
thresholds 
 
A direct comparison with other implantable hearing devices indicated for mixed hearing 
loss is impossible, since the published data for the Soundbridge (placed on the round 
window) and the Carina (coupled to the round window) are based on patient populations 
that have considerable lower hearing loss than the patients of the DACS clinical trial. 
Nevertheless the study results suggest that the DACS device provides higher gain in 
terms of speech understanding and improved hearing threshold than reported for the 
other systems. 
 
6.1.3 Implantation 
The four implantations that were accomplished by experienced ear surgeons have shown 
that simple and safe handling procedures are very important to prevent damaging the 
fragile actuator. This concerns packaging design and handling tools. Concretely it was 
observed that critical forces could impact on the artificial incus when the implant is 
improperly taken out of its packaging. 
 
The manipulation of the actuator with standard surgical forceps caused difficulties as well. 
The grip between the instrument and the actuator was not always sufficient, and the 
limited number of gripping positions caused difficulties in some cases during the 
placement of the actuator. 
 
These are good examples that highlight again the importance of a holistic design 
approach. Good usability is of central interest for such a delicate device that requires high 
handlings skills. The success of the therapy depends as much on the work of the surgeon 
as on the device characteristics. Therefore the product design has to support the user as 
much as possible and to prevent unintended manipulation whenever possible – especially 
in the case of a medical device. 
 
6.1.4 Device 
Technical verification and clinical validation have shown that the investigational DACS 
device meets the performance requirements and provides sufficiently high stimulation 
levels to treat severe to profound mixed hearing loss. Further, records of over five years  
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of operation in patients and over six years of continuous life cycle testing in the lab show 
that the device is reliable and operates permanently within its specifications. This proves 
that the device is sufficiently robust and reliable to serve as long term implantable device 
as required for a hearing implant. 
 
The major device drawback concerns the percutaneous connection between the external 
audio processor and the implanted actuator. On the one hand, it required some training of 
the patients until they were able to correctly connect the processor plug to the implanted 
pedestal. On the other hand, the percutaneous pedestal caused infections of the 
surrounding tissue. 
 
Another issue concerned the placement of the actuator. It was difficult to position the 
artificial incus sufficiently precisely over the oval window. The provided degrees of 
freedom for the fine tuning of the actuator position were not sufficient, because the 
actuator axis could not be changed anymore once the fixation system was screwed to the 
skull. 
 
6.2 Originality 
6.2.1 Conceptual Design Methodology 
The design of an acoustic hearing implant is a very challenging task. This is confirmed by 
the analysis of existing devices (sub-section 2.2.2) that all show one or another 
imperfection. The observed imperfections can be attributed to conceptual design 
decisions in most of the cases. Therefore it is essential to better structure and guide the 
conceptual design process by formalizing a dedicated methodology. Since no 
corresponding basis could be found in literature, the presented conceptual design 
methodology is elaborated from scratch. It consists of a step-by-step procedure and a 
diagram tool that visualizes the system, its environments and the corresponding 
interactions. The described methodology merges the three essential definition steps of a 
medical device development that are normally executed in sequence to one procedure. 
This approach minimizes the risk of isolating the technical development from the initial 
user requirements of an acoustic hearing implant. 
 
The presented approach focuses on the conceptual design phase in order to maximize 
the overall device performance. Especially in the field of active implantable medical 
devices, where technology has to be joined to living tissue, the global optimum has to be 
searched on concept level. Pure technical benchmarks that are maximized during the 
detailed design phase are less relevant in this case. 
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6.2.2 Resulting Innovative Actuator Design 
A side effect of the applied conceptual design methodology was that the solutions for the 
individual functions are “enforced” by their environments. The fact that the acoustical 
hearing implant was developed for severe to profound mixed hearing loss influenced 
considerably the actuator design. 
 
Further, the consideration of the interactions between the different actuator functions as 
well as between the actuator and its environments led to an integrated design solution 
instead of a compromise. 
 
The resulting actuator is the first one that was consequently designed for the treatment of 
mixed hearing loss and differs form other existing hearing implant actuators. Its most 
remarkable characteristic is that the encapsulation was considered as a functional part 
and included into the actuation concept. This allowed to minimize losses and to optimize 
the actuator frequency response. 
 
6.3 Outlook 
6.3.1 Methodology Refinements 
The proposed conceptual design methodology provided satisfying outputs in the present 
case. The procedure was easily applicable and has well supported the conceptual design 
process. Hence there is currently no concrete suggestion to refine the methodology. 
 
It would be interesting to apply the methodology for the development of other acoustic 
hearing implants to further verify its validity. Of particular interest would be to investigate 
how the actuator design changes in function of alternative requirements. 
 
The methodology might also be of interest for the development of artificial organs in 
general. Trials would have to show if the design principles that are adapted to the ear are 
also valid for the eye or the heart for example. 
 
6.3.2 Implementation of Transcutaneous Link 
The central weakness of the DACS investigational device is the percutaneous signal 
transmission. Comparable semi-implantable hearing devices are equipped with a wire-
less transcutaneous power and signal transmission which provides much higher patient 
comfort. Fig. 6-1 shows the second generation DACS device with implemented 
transcutaneous transmission. 
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Fig. 6-1:  Ingenia from Phonak Acoustic Implants: 1) Microphones pick up sound, 2) 
Sound processor, 3) Energy and signal are sent wireless through the skin, 4) 
Implanted electronics, 5) Actuator and 6) Stapes prosthesis [53] 
 
6.3.3 Expansion of Device Indication 
The promising results of the clinical trial have shown that the DACS therapy provides high 
potential for the expansion of its current indication. Especially, so called, radical cavities 
could be an ideal indication for the device. Radical cavities are middle ears that had to be 
completely cleared out in order to cure chronic otitis media. 
 
The DACS device could also be indicated for the large group of pure sensorineural 
hearing loss patients. The question that has to be answered upfront is, if the risk of 
opening up the inner ear is justified in this case. The currently running clinical multicenter 
studies will show if the DACS therapy is sufficiently safe. 
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Glossary of Symbols 
AL armature length 
AR armature radius 
ASL armature shaft length 
ASR armature shaft radius 
ASTM American Society for Testing and Materials 
BAHA bone anchored hearing aid 
β electro-mechanic conversion constant 
BTE behind the ear (hearing aid) 
c actuator damping coefficient 
CCIR coil core inner radius 
CCL coil core length 
CI cochlear implant 
CIC completely in the canal (hearing aid) 
CIR coil inner radius 
cL mechanical impedance of the cochlea 
CL coil length 
COR coil outer radius 
CSIR coil shell inner radius 
CSL coil shell length 
DACS direct acoustic cochlear stimulation 
DC direct current 
EN European Norm 
ETi Young's modulus of titanium 
ETO ethylene oxide 
F complex magnetic force 
FMT floating mass transducer 
fres resonance frequency 
g gravitational acceleration 
GL gap length 
GPL gap part length 
HA hearing aid 
HL hearing loss 
i complex coil current 
id inner diameter 
ISL iron shim length 
ISO International Organization for Standardization 
ITC in the canal (hearing aid) 
ITIR iron tube inner radius 
ITL iron tube length 
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j imaginary unit 
k actuator spring constant 
kD spring constant attributed to the magnets 
kM spring constant attributed to the diaphragm 
L actuator inductance 
LDV Laser Doppler Vibrometer 
m mass 
M.E.T. middle ear transducer 
MEI middle ear implant 
MES middle ear surgery 
MIL-STD Military Standard 
MIR magnet inner radius 
ML magnet length 
MOR magnet outer radius 
νTi Poisson coefficient of titanium 
od outer diameter 
ω circular frequency 
OR outer radius 
P real power 
φ phase angle 
R electrical resistance 
SPL sound pressure level 
SR system requirement 
th thickness 
TICA totally implantable cochlear amplifier 
TORP total ossicular chain replacement prosthesis 
u complex coupling voltage 
U1mW voltage corresponding to 1 mW power consumption 
ue complex actuator excitation voltage 
UR user requirement 
v complex armature velocity 
Ym complex mechanical actuator admittance 
Z complex electrical actuator impedance 
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